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 The presequence pathway is utilized by over 70% of all cytosolically translated 
proteins destined to the mitochondria, emphasizing the significance imparted by 
presequence import on mitochondria translocation. Presequence docking at the main 
mitochondrial entry gate, the translocase of the outer mitochondrial membrane (TOM), has 
been the target of a vast number of publications throughout the past two and a half 
decades. However, the dynamic docking events leading up to the engagement of the 
presequence with the TIM23 complex (also known as the presequence translocase) is still 
poorly understood. 
 This study presents Tom40 as a presequence-active TOM complex subunit, and 
maps its presequence-interacting sites employing presequence probes in a joint photo-
crosslinking/mass spectrometry based approach. Moreover, the interacting regions of 
Tom40 were placed within a recently published, biochemically grounded Tom40 
homology model, where two presequence-active regions were identified. A 
posttranslationally active residue was identified within one of the defined presequence-
interacting surfaces. Phospho-mimetic and phospho-block Tom40 point mutants were 
shown to selectively augment local presequence import kinetics at the TOM complex, 
resulting in alteration of overall import kinetics. Finally, the established intermembrane 
space (IMS) domain of Tom22 was functionally linked to Tom40 presequence interaction. 
 Examining the following stages of presequence import, this study presents a series 
of dynamic subunit exchange events leading to presequence presentation at the channel of 
the presequence translocase. A novel presequence translocase interaction between Tim50 
and Tim21 was characterized and shown in vitro to be coordinated by the IMS domain of 
Tim23 via a Tim50 interaction mechanism. Moreover, the interaction of Tim50 and Tim21 
was shown in organello to be signal sequence sensitive, as Tim21 is demonstrated to 
dissociate from Tim50 within the presequence translocase in a presequence-“priming” 
dependent manner. Finally, the aforementioned presequence translocase priming event is 
linked to matrix translocation as the early presequence associated motor (PAM) subunit 
Pam17 was shown to be recruited to the TIM23 complex concomitantly with Tim21 
dissociation during TIM23 priming. 
 Taken together, these data shine new light on the presently elusive transfer 
mechanism of presequence-containing substrates from the outer membrane resident TOM 
channel to the inner membrane bound TIM23 complex.
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1.  INTRODUCTION 
 
1.1.  The birthplace of endosymbiotic organelles 
 The eukaryotic cell is set apart from its prokaryotic counterpart by the presence of 
intracellular membrane-enclosed organelles (Palade, 1964). Virtually all of these 
organelles are part of the characteristic endomembrane system, which facilitates the 
partitioning of the cell interior, allowing for the segregation of various biochemical 
processes. Mitochondria and plastids are the only omissions to this intracellular membrane 
system due to their non-host origin. These evolutionarily distinct organelles arose through 
systematic endosymbiotic events with the conception of mitochondria preceding that of the 
plastids (Gross and Bhattacharya, 2009). In the case of the mitochondrion, strong evidence 
exists illustrating the occurrence of an endosymbiotic event in which a Gram-negative 
purple non-sulfur bacteria (α-proteobacteria) was phagocytosed by a protoeukaryote host 
cell (Gray et al., 1999). Following engulfment, the α-proteobacteria likely escaped from 
the food vacuole and was free to incorporate fitness-conferring host cell proteins through 
protomitochondrial resident outer membrane (OM) proteins (Cavalier-Smith, 2006). This 
endosymbiotic event is believed to have occurred approximately two billion years ago 
(Bhattacharya et al., 2007; de Duve, 2007; Dolezal et al., 2006; Dyall, 2004). Following 
the initial engulfment event, endosymbiont resident genes were transferred to the host 
genome through four predominant gene transference mechanisms; endosymbiotic gene 
transfer, de novo gene construction, horizontal gene transfer and co-option of existent host 
functions (Gross and Bhattacharya, 2009). It has been suggested on numerous occurrences 
that the selection pressure for the migration of protomitochondrial genes to the nucleus was 
due to advantages conferred to the host regarding α-proteobacterial energy production via 
oxidative phosphorylation (Andersson et al., 2003; Kurland and Andersson, 2000). 
Therefore, fitness-conferring novel gene transference events leading to increased energy 
production efficiency rewrote the protomitochondrial genome. This process resulted in the 
shrinking of its size from an estimated 603 distinct genes (Gabaldón and Huynen, 2003) to 
the mitochondrial genome as we know it today, encoding 8 proteins in yeast (S. cerevisiae) 
and 13 proteins in humans. The retention of these select few mitochondria-encoded genes 
demanded the preservation of a complete array of transcriptional and translational systems. 
Importantly, this mandated the coevolution of a highly sophisticated network of dynamic 
import translocases, competent in the concomitant intraorganellar sorting of an enormous 
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number of nuclear-encoded protein and RNA substituents within the mitochondrion. This 
apparent energetics conundrum, in which several orders of magnitude more anabolically 
active biomolecules must be transcribed and translated outside of the organelle and 
subsequently imported to give rise to the seemingly insignificant number of mitochondria-
encoded genes, has baffled researchers for nearly a century. 
 Succinctly, evolution has betrothed these endosymbiotic organelles with a vital and 
unique set of functions (energy production, amino acid and lipid metabolism, biosynthesis 
of Fe-S clusters and apoptosis) required by all forms of eukaryotic life, thereby instilling 
an essential metabolic role upon these extraordinary organelles. 
 
1.2. The mitochondrial respiratory chain, the oxidative phosphorylation system 
 Arguably the most recognized metabolic function of the mitochondrion is the 
production of energy-rich biologically active compounds by way of oxidative 
phosphorylation (OXPHOS) to meet the cellular energy demands. OXPHOS mediated 
energy production in the mitochondria can be separated into two major events: (i) the 
production of a proton based electrochemical gradient (membrane potential [∆ψ]) across 
the inner mitochondrial membrane through the enzymatic oxidation of reducing 
equivalents (NADH and FADH2) obtained from central catabolic metabolic processes, e.g. 
the tricarboxylic acid cycle, (ii) the utilization of the ∆ψ to drive the production of the 
stable high energy molecule, ATP. 
The first of the aforementioned steps is performed by the respiratory chain 
complexes of the mitochondrial inner membrane (IM) (Fig. 1). In S. cerevisiae, the 
respiratory chain contains three complexes which mediate the oxidation of reducing 
equivalents, these being succinate dehydrogenase (II), the cytochrome bc1 complex (III) 
and the cytochrome c oxidase complex (IV), and two electron-shuttling entities (coenzyme 
Q and cytochrome c) (Stuart, 2008) (Fig. 1A). Moreover, in yeast, no true complex I exists 
and subsequently the oxidation of NADH is carried out by three membrane-bound 
proteins, Nde1, Nde2 and Ndj1. In yeast, complexes III and IV serve to produce the proton 
motive force (PMF), which is utilized by the F1Fo-ATP synthase (also called complex V) 
(Fig. 1A). Additionally, the S. cerevisiae mitochondrial genome encodes for eight proteins, 
seven core catalytic subunits of the respiratory chain and one component of the 
mitochondrial ribosome (Lipinski et al., 2010) (Fig. 1A). 
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 The OXPHOS situation in the human mitochondrial IM is slightly different from 
yeast, with the respiratory chain containing a true NADH dehydrogenase (complex I), 
which in combination with complex III and IV contribute to the ∆ψ across the IM (Papa et 
al., 2012) (Fig. 1B). Another major discrepancy from yeast seen in the human respiratory 
chain is the number of mitochondria-encoded respiratory chain subunits. The human 
mitochondrial genome encodes 13 different proteins, all of which are compounds of the 
respiratory chain, with a majority being key subunits of the NADH dehydrogenase, 
complex I. 
 Refuting the original conception that the mitochondrial respiratory chain complexes 
were randomly distributed in the IM (the fluid model) (Hackenbrock et al., 1986; Hatefi, 
1985), the discovery of the mild non-ionic detergent digitonin in conjunction with the 
establishment of blue native polyacrylamide gel electrophoresis (BN-PAGE) shook up the 
field (Cruciat et al., 2000; Schägger and Pfeiffer, 2000). In these key early publications, it 
was shown that the respiratory chain is organized in higher order supercomplexes, and the 
concept of the mitochondrial respirasome was introduced. Moreover, later studies utilized 
negative stain or cryo-electron microscopy to image detergent solubilized higher order 
respiratory chain structures (referred to as respirasomes) (Althoff et al., 2011; Dudkina et 
al., 2011; Schäfer et al., 2006). Today, the existence of respirasomes is widely accepted 
and known to contain complexes I (in higher eukaryotes), III and IV (Winge, 2012). 
However, it should be noted that there are a few skeptics in the field (Barrientos and 
Ugalde, 2013). Recent findings have provided genetic evidence for respiratory chain 
supercomplexes, as respirasome dynamics were shown to dictate the electron flux in 
















Figure 1. A schematic representation of the mitochondrial respiratory chain, illustrating the 
electron flux through the individual respiratory complexes. Red arrows indicate the flow of 
protons throughout the respiratory chain. (A) Cartoon depiction of the S. cerevisiae respiratory chain 
consisting of complexes II – V with all of the mitochondria-encoded subunits in pink with a yellow 
outline. (B) Cartoon depiction of the human respiratory chain consisting of complexes I – V with all 
of the mitochondria-encoded subunits in pink with a yellow outline. Complex I (human only) – 
NADH dehydrogenase, complex II – succinate dehydrogenase, complex III – cytochrome bc1 
complex, complex IV – cytochrome c oxidase and complex V – F1Fo-ATP synthase. e-, electron. CoQ, 
coenzyme Q. Cyt c, cytochrome c. IMS, intermembrane space. IM, inner membrane. 
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1.3. Mitochondrial protein import 
 Over 99% of all mitochondrial resident proteins are nuclear-encoded, translated on 
cytosolic ribosomes and posttranslationally imported into one of the organelle’s four 
subcompartments (Pfanner et al., 2004). Due to the multitude of different intraorganellar 
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of unifying mitochondrial-targeting signals has evolved (Chacinska et al., 2009). These 
signals have been divided into two major classes, these being the well-defined N-
terminally located mitochondrial presequence (Fig. 2A) and the highly heterogeneous class 
of internal-targeting signals (Fig. 2B – E). The class of internal-targeting signals consists 
of all mitochondrial-orienting signals that cannot be characterized as a presequence. In 
brief, these signals are subclassified as the IM targeting signal of the carrier pathway (Ryan 
et al., 1999; Wagner et al., 2008; Wiedemann et al., 2001), the C-terminally located β-
signal (present in OM β-barrel proteins) (Kutik et al., 2008), the intermembrane space 
(IMS) directing cysteine-containing signals of the mitochondrial intermembrane space 
import and assembly (MIA) pathway (Gabriel et al., 2007; Milenkovic et al., 2007; 2009) 
and the N- or C-terminal (signal or tail anchor sequence, respectively) α-helical type 
present in α-helical OM proteins (Becker et al., 2011; Papic et al., 2011; Setoguchi et al., 
2006; Stojanovski et al., 2007). 
! 7!
!
Figure 2. Mitochondrial targeting signals and corresponding import and sorting routes. (A) 
Presequence-containing substrate enters the mitochondrion via the translocase of the outer membrane 
(TOM). At the inner membrane (IM), presequence-containing substrates interact with the presequence 
translocase (TIM23) in either the SORT (sorting signal containing substrates) or MOTOR form, 
which contains the presequence associated motor (PAM). Matrix processing peptidase, MPP. (B) 
Substrates of the carrier pathway enter the mitochondrion through TOM and interact with small TIMs 
after entering the intermembrane space (IMS), shuttling the substrate to the TIM22 complex. (C) β-
signal containing substrates (β-barrel proteins of the outer membrane [OM]) are imported first via 
TOM and then handed off to the sorting and assembly machinery (SAM). (D) CxnC containing 





























assembly (MIA) pathway. (E) Single and multiple transmembrane domain containing α-helical OM 
proteins are integrated into the OM via the Mim1 complex. 
 
1.3.1. Import of presequence-containing proteins, the presequence pathway 
 Presequences are characterized as N-terminally located, net positively charged, 
amphipathic α-helices. Mass spectrometry based analyses have estimated that 
approximately 70% of mitochondrial substrates contain cleavable presequences (Vögtle et 
al., 2009), however, many noncleavable presequence-containing substrates have already 
been characterized, significantly increasing the size of the presequence-containing 
substrate class. Therefore, the presequence pathway represents the single most important 
mitochondrial entry route. The presequence pathway allows for substrates to be fully 
imported into the mitochondrial matrix or for a single transmembrane span to be inserted 
into the mitochondrial IM (Fig. 3). Presequence mediated import commences at the main 




















































Figure 3. The mitochondrial presequence pathway. (A) Presequence-containing substrate entering 
the mitochondrion via the translocase of the outer membrane (TOM), functionally interacting with 
Tom20, Tom22, Tom5 and Tom40. At the inner membrane (IM), presequence-containing substrates 
interact with the presequence translocase (TIM23) in either the SORT (sorting signal containing 
substrates) or MOTOR form for translocation of single transmembrane domain containing precursors 
into the inner membrane or matrix translocation utilizing the presequence associated motor (PAM) 
followed by potential presequence removal by the matrix processing peptidase (MPP), respectively. 
OM, outer membrane. 
 
The TOM complex is the main entry gate into the mitochondrion, translocating all 
mitochondrial substrates with the exception of several OM integrated proteins (see section 
1.3.5. for details) (Endo and Yamano, 2010). Cryo-EM analysis has resolved the core 
structure to a resolution of 18 Å and 3D reconstruction produced a near three-fold 
symmetrical complex with three pores (each with the dimensions 15 Å x 25 Å) on one side 
which converge to a single cavity on the opposite side (Model et al., 2008). The core of the 
TOM complex is extremely stable (Meisinger et al., 2001) and comprised of the essential 
Tom40, the β-barrel pore-forming subunit (Becker et al., 2005; Hill et al., 1998; Suzuki et 
al., 2004), and Tom22, the central presequence receptor which exposes presequence 
recognition domains to both the cytoplasm as well as the IMS (Brix et al., 1997; Moczko et 
al., 1997). Additional subunits of the TOM complex are Tom70 (serves as a receptor for 
hydrophobic substrates such as carrier and ß-signal substrates [see section 1.3.2. and 1.3.3. 
for details, respectively]), Tom20 (the initial presequence receptor [Saitoh et al., 2007]), 
Tom71 (a low abundant Tom70 homolog [Schlossmann et al., 1996]), Tom 5 (a TOM 
assembly factor and presequence receptor [Dietmeier et al., 1997]), Tom6 (a TOM 
assembly factor [Kassenbrock et al., 1993]) and Tom7 (a TOM disassembly factor 
involved in TOM dynamics [Hönlinger et al., 1996]). 
 Mitochondrial association with presequence-containing substrates commences with 
their interaction with Tom20 (Saitoh et al., 2007). The obtainment of structural data of 
Tom20 in complex with a presequence has imparted the field of mitochondrial import with 
a wealth of data, as it represents the first published structurally based receptor presequence 
interaction information (Abe et al., 2000). This study confirmed the suspected hydrophobic 
mode of interaction between the presequence and the Tom20 receptor domain (Brix et al., 
1997). Following the interaction with Tom20, the presequence is transferred to the 
cytosolic receptor domain of the central receptor of the TOM complex, Tom22 (van Wilpe 
et al., 1999). The interaction of the presequence with Tom22 has been shown to be 
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mediated by ionic forces (Brix et al., 1997), leading to the conception of the possible 
simultaneous binding, tertiary complex formation, of the presequence by both Tom20 and 
Tom22 (Shiota et al., 2011; Yamano et al., 2008). After the presequence has reached the 
central receptor, it is passed to Tom40, with the assistance of the small protease resistant 
TOM receptor, Tom5 (Dietmeier et al., 1997). At this point, the presequence is believed to 
be passed through the Tom40 pore and passed to the trans-binding site of the TOM 
complex, the presequence-binding IMS domain of Tom22 (Komiya et al., 1998; Moczko et 
al., 1997; Shiota et al., 2011). The IMS domain of Tom22 has been shown to play an 
important presequence-anchoring role under suboptimal import conditions such as 
increased ionic stress, a reduction in ∆ψ, the addition of a tightly folded substrate on the 
cis side of the TOM complex or the protease mediated removal of cytosolically exposed 
presequence receptors (Chacinska et al., 2003; Komiya et al., 1998; Moczko et al., 1997). 
However, it should be mentioned that the exact OM translocation mechanism is presently 
elusive, as the deletion of the lone established trans-binding site at the TOM complex has 
no growth phenotype in yeast and only a minute retardation in import kinetics (Chacinska 
et al., 2003; Frazier et al., 2003; Moczko et al., 1997). This finding strongly suggests the 
existence of additional post Tom5 presequence-binding sites at the TOM complex. 
 Tom40, positioned functionally downstream of Tom5, has long been observed to 
interact with presequence-containing substrates. In 1989, Tom40 was the first identified 
mitochondrial translocation related protein (Vestweber et al., 1989). Vestweber and 
colleagues used an arrestable artificial chimeric mitochondrial substrate containing a 
photo-reactive crosslinker, and obtained strong photo-adduct formation to a protein of 42 
kDa. Shortly after, the deletion of the corresponding gene in yeast was shown to lead to the 
cytosolic accumulation of mitochondrial substrates, resulting in death (Baker et al., 1990). 
Today, it is known that Tom40 is the key channel forming subunit in the TOM complex 
(Neupert and Herrmann, 2007). Moreover, the TOM complex is the main entry gate into 
the mitochondrion, with all substrates destined past the OM passing through its 
translocation pore, largely explaining the early observation by Vestweber et al.  
 Ever since the discovery of Tom40’s central role in mitochondrial protein 
translocation, it has been suggested to play an active role in mediating the translocation of 
presequence-containing substrates. Case in point, in 1997 Rapaport and others observed 
direct interaction of Tom40 with a presequence-containing substrate (Rapaport et al., 
1997). Specifically, Tom40’s interaction with presequence-containing substrates was 
shown to be independent of other cytosolically exposed, trypsin sensitive (Tom20, Tom22 
! 11!
and Tom70), receptors of the TOM complex. Additionally, Tom40 was shown to make 
contact with the translocating substrate both at the cis and trans surfaces, utilizing a 
previously published differential salt wash technique (Mayer et al., 1995). Since the initial, 
aforementioned publications, postulating Tom40’s direct interaction with mitochondrially 
targeted substrates, numerous additional studies have attempted to demonstrate its direct 
functional interaction in regards to presequence import (Gaikwad and Cumsky, 1994; 
Gordon et al., 2001; Juin et al., 1997; Kanamori et al., 1999; Rapaport et al., 1998a; 1998b; 
Stan et al., 2000). However, the characterization of a dedicated presequence-binding 
domain within the Tom40 channel has only been theorized (Ahting et al., 2001; Gabriel et 
al., 2003; Gessmann et al., 2011; Hill et al., 1998; Künkele et al., 1998; Mahendran et al., 
2012; Sherman et al., 2006). 
When the presequence emerges from the trans side of the TOM complex it can 
interact with the IMS domain of Tom22 as mentioned above. However, it is known that 
this interaction is not necessary for efficient import (Chacinska et al., 2003; Frazier et al., 
2003; Moczko et al., 1997) and that a key essential presequence receptor of the translocase 
of the inner mitochondrial membrane (TIM23, presequence translocase) participates in the 
stabilization of late stage TOM intermediates (Chacinska et al., 2005). This early acting, 
primary presequence-interacting, IM bound presequence translocase receptor is Tim50 
(Schulz et al., 2011). Tim50 contains a large IMS domain, which has been shown to 
possess two presequence-binding domains; one of which, at the C-terminus, was shown to 
be essential (Qian et al., 2011; Schulz et al., 2011). When Tim50 is bound by a 
presequence, it triggers key initial translocation steps within the presequence translocase 
(Lytovchenko et al., 2013; Meinecke et al., 2006; Mokranjac et al., 2009; Qian et al., 2011; 
Rahman et al., 2014). 
 The presequence translocase consists of three essential proteins, Tim23, Tim17 and 
Tim50 (Dudek et al., 2013). Tim23 is the major pore-forming subunit of the complex and 
its gating has been shown to be dependent on both the ∆ψ and presequences (Bauer et al., 
1996; Truscott et al., 2001). Moreover, it contains a very large N-terminal IMS domain 
which was shown to interact with presequences and mediate import conferring initial 
translocase rearrangements (Komiya et al., 1998; Lytovchenko et al., 2013). Tim17 is 
involved in the stability of the Tim23 channel as well as acting as a sensor for various 
substrate types (Chacinska et al., 2005; Martinez-Caballero et al., 2007; Meier et al., 
2005). However, an exhaustive description of Tim17’s functions is still elusive. Tim50, in 
addition to the aforementioned role, has been shown to be functionally associated with the 
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regulation of the TIM23 channel (Meinecke et al., 2006). In a study by Meinecke et al., 
Tim23 was reconstituted and its electrophysical characteristics were monitored, leading to 
the observation that the primarily open channel would spontaneously remain closed for 
extended periods of time after the addition of the IMS domain of Tim50 (Meinecke et al., 
2006). This study highlighted Tim50’s key role in maintaining the PMF over the IM. 
 Additional, nonessential components of the presequence translocase are Tim21 and 
the newly established Mgr2. Tim21 is known to couple the presequence translocase to the 
respiratory chain, specifically complexes III and IV (van der Laan et al., 2010). This 
association was shown to assist the insertion of presequence-containing substrates into the 
IM, a process known not to require the import motor, but specifically dependent on the ∆ψ 
(Gambill et al., 1993; van der Laan et al., 2007; 2006). Moreover, Tim21 has been 
implicated in the early steps of IM based translocation; specifically it has been speculated 
to play a role in the removal of the presequence from the TOM trans-binding site 
(Tom22IMS) as it competitively binds (Albrecht et al., 2006; Chacinska et al., 2005; 
Mokranjac et al., 2005). Mgr2 was recently assigned as a presequence translocase 
component, as it was found to attach Tim21 to the presequence translocase as well as play 
a role in the transfer of presequence-containing proteins from the TOM complex to the 
presequence translocase (Gebert et al., 2012). 
 As exemplified by the complexity of interactions listed above, the precise path the 
presequence takes upon its exit from the TOM channel to the passage of the IM at the 
presequence translocase; namely the exact sequence of interactions with the presequence, 
is still not completely understood. However, the generally accepted route is as follows: (i) 
The emerging presequence from the Tom40 channel is captured by Tim50 through the 
possible assistance of Tom22IMS and Tim21; (ii) Presequence-bound Tim50 associates with 
Tim23, causing the release of Tim21 from the presequence translocase and the hand-over 
of the presequence to the Tim23 channel, initiating channel opening in a ∆ψ dependent 
manner; (iii) The release of Tim21 causes the subsequent association of a key presequence 
associated motor (PAM) subunit, Pam17, triggering the subsequent association of the main 
translocation conferring PAM subunits, required for the full translocation of the substrate 





1.3.1.1. The presequence translocase associated motor, PAM 
After the Tim23 channel has been opened, the presequence is initially pulled 
through the IM and into the matrix due to the electrophoretic force exerted on the 
presequence by the ∆ψ (Martin et al., 1991). Following the passage of the presequence into 
the matrix, the forward driving motion of the substrate is conferred by the PAM complex 
(Fig. 3, PAM constituents in green) (Chacinska et al., 2009; van der Laan et al., 2010; 
Wiedemann et al., 2004a). The PAM complex consists of the force conveying, ATP-
dependent subunit, mtHsp70 (Ssc1) (Kang et al., 1990; Liu et al., 2003; Ungermann et al., 
1994; Voisine et al., 1999), and the cochaperones Pam18, Pam16, Pam17, Tim44 and 
Mge1 (van der Laan et al., 2010). Until 2003, the PAM complex was thought to contain 
only the mtHsp70, Tim44 and Mge1 (Miao et al., 1997; Schneider et al., 1994; 1996), in 
which Tim44 served to tether mtHsp70 to the presequence translocase and the nucleotide 
exchange factor Mge1 served to replenish the mtHsp70 import cycle. The discovery of 
several key PAM components quickly led to the first models on how the motor conveyed 
inward driving force. Two motor models arose; one of which, the Brownian ratchet model, 
advocated that the major precursor interacting subunit, mtHsp70, trapped the translocating 
polypeptide in the matrix and thereby prevented backsliding, solely relying on Brownian 
motion for inward movement (Ungermann et al., 1994). The second mechanistic PAM 
model, the power stroke model, hypothesized that the mtHsp70 actively pulled the 
substrates into the matrix and discarded the functionality of a forceless import model 
(Voisine et al., 1999). Although both models have now been discussed for nearly two 
decades, no study has yet to concretely discredit the other. Moreover, a compromise of 
both models, the Brownian ratchet model for loosely folded substrates and the power 
stroke model for tightly folded precursors, has been presented (van der Laan et al., 2010). 
In the early 2000’s, the discovery of three additional PAM components, Pam18, 
Pam16 and Pam17, strongly suggested that any simple mechanistic explanation of the 
PAM complex is likely not accurate. Pam18 contains a single transmembrane span with a 
small IMS domain and a highly conserved matrix localized J-domain (D'Silva et al., 2003; 
Mokranjac et al., 2003; Truscott et al., 2003). The J-domain (named after prokaryotic 
protein DnaJ) interacts with mtHsp70 and stimulates the ATPase activity (Walsh et al., 
2004). Pam16 was found in a stable complex with Pam18 and is required for the 
association of the heteroligomer to the presequence translocase (D'Silva et al., 2008; 2005; 
Frazier et al., 2004; Kozany et al., 2004; Mokranjac et al., 2007; 2006), however, 
interestingly Pam16 was found to inhibit the ATPase activity of mtHsp70 via its J-like 
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domain and therefore likely acts in the fine-tuning of the import motor activity (Li et al., 
2004). Furthermore, the crystal structure of the Pam18/Pam16 complex clearly illustrates 
the tight association of the two proteins (Mokranjac et al., 2006), a complex strangely also 
shown to directly interact with the respiratory chain (Wiedemann et al., 2007). Pam17 is a 
membrane-integrated protein with two membrane-spanning domains, and was shown to be 
vital for the association of the Pam18/Pam16 complex to the presequence translocase 
(Popov-Celeketić et al., 2008a; van der Laan et al., 2005). Finally, Pam17, was recently 
shown to exhibit dynamic association with the presequence translocase, in direct response 
to presequence mediated priming events at the cis side of the TIM23 complex 
(Lytovchenko et al., 2013). These key translocase priming steps have long been observed 
(Dudek et al., 2013; van der Laan et al., 2010), and have led to the highly debated proposal 
of two functionally distinct TIM23 complexes (Chacinska et al., 2005). 
 
1.3.1.2. Presequence translocase dynamics, TIM23MOTOR and TIM23SORT 
 The presequence translocase is a unique translocase of the inner mitochondrial 
membrane as it is competent in both the matrix translocation of presequence-containing 
substrates as well as the membrane insertion of single transmembrane domain-containing 
substrates. The fulfillment of these distinct tasks is performed by two compositionally 
different presequence translocases, these being the TIM23MOTOR for the matrix 
translocation of precursors and TIM23SORT for the membrane insertion of transmembrane 
domain-containing precursors (Fig. 2) (Chacinska et al., 2005; 2010). TIM23SORT has been 
shown to migrate more slowly than other TIM23 complexes on BN-PAGE and consists of 
the core essential TIM23 subunits, Tim23, Tim17 and Tim50, as well as Mgr2 and Tim21. 
TIM23MOTOR contains all subunits of the TIM23SORT isoform, with the exception of Tim21, 
as well as the PAM (Dudek et al., 2013). The existence of multiple presequence 
translocase pools requires that the translocase possesses sensor-acting subunits, able to 
distinguish between a matrix and an IM integrated precursor. Moreover, the translocase 
must appropriately respond to the incoming sensors, gearing up for the proper translocation 
of the incoming substrate. The exact nature of the translocase associated sensor-acting 
subunits is still unknown; however, many studies have demonstrated the dynamics of the 
presequence translocase in the response to different substrate-based targeting signals 
(Chacinska et al., 2005; 2010; Lytovchenko et al., 2013; Popov-Celeketić et al., 2008a). 
Nearly all presequence translocase targeted substrates have a presequence, however, 
exceptions such as Sym1 have been characterized (Reinhold et al., 2012). Yet what 
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distinguishes whether or not they are laterally released from TIM23SORT or translocated 
fully into the matrix by TIM23MOTOR is the presence or absence of a stop-transfer signal 
(Glick et al., 1992). The stop-transfer signal is located downstream of the presequence and 
consists of a hydrophobic stretch, which stalls the matrix translocation and then initiates 
the lateral release from TIM23SORT preceding through a presently elusive mechanism, 
known to involve Tim17 (Bömer et al., 1997; Chacinska et al., 2005). Interestingly, the 
composition of the stop-transfer signal has been shown to be enriched in tyrosine and 
phenylalanine residues, and that the addition of a proline within the stop-transfer sequence 
leads to complete matrix translocation of IM targeted proteins (Miller and Cumsky, 1993; 
Neupert and Herrmann, 2007). 
 The true existence of two separate presequence translocases was strongly supported 
by the publication of a motor-free in vitro reconstituted TIM23 import system (van der 
Laan et al., 2007). van der Laan and colleagues were able to demonstrate the minimal 
TIM23 import system for the import of membrane integrated substrates which they showed 
to be dependent upon a voltage-potential and a cardiolipin-rich membrane. Importantly, 
this system utilized isolated translocase from yeast mitochondria, free of PAM constituents 
(van der Laan et al., 2007). Moreover, Tim21 was shown to play a major role in 
differentiating the motor and sort isoforms, as it was found only in TIM23SORT (Chacinska 
et al., 2005; van der Laan et al., 2006; 2007). The multiple isoform TIM23 model is not 
unanimously supported by the field, as other publications have shown the association of 
PAM subunits with TIM23SORT and have advocated for a single translocase model (Popov-
Celeketić et al., 2008a; Tamura et al., 2009; 2006), however, only substoichiometric 
amounts were found to be associated.  
Finally, cooperation between both presequence translocase isoforms has been 
observed (Bohnert et al., 2010). Bohnert et al. have uncovered the presequence translocase 
substrate Mdl1, a member of the ABC transporter family, which contains three pairs of two 
transmembrane spans. Interestingly, the first and third transmembrane spans are inserted 
into the IM via TIM23SORT, and the second set is first completely translocated into the 
matrix via TIM23MOTOR where it is inserted into the IM through an Oxa1, a YidC homolog 
(van der Laan et al., 2003), dependent mechanism. The characterization of the Mdl1 import 
pathway presents a novel mechanistic description of the presequence translocase, namely 
its capacity to functionally interconvert between its two functional states during the import 
of a substrate. 
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1.3.1.3. Presequence import, the TOM-TIM23 supercomplex and TOM energetics 
 The translocation across the mitochondrial OM via the TOM complex is believed 
to occur independent of direct ATP hydrolysis (Asai et al., 2004; Endo and Yamano, 
2010). ATP hydrolysis is known to be required to preserve import compatibility through 
the retention of an unfolded state in many hydrophobic mitochondrial substrates, however, 
the direct requirement of ATP hydrolysis for OM passage was never directly shown (Endo 
and Yamano, 2010). This predicament would inevitably lead one to question the energetics 
of OM passage. An exhaustive description of TOM energetics is still elusive (Neupert and 
Herrmann, 2007), yet in the case of a particular subset of presequence-containing 
substrates an explanation has been presented (Dudek et al., 2013; van der Laan et al., 
2010). The existence of two-membrane-spanning translocation supercomplex 
intermediates has long been observed (Pon et al., 1989; Rassow et al., 1989; Schleyer and 
Neupert, 1985; Schülke et al., 1997; Schwaiger et al., 1987), even predating the discovery 
of the first mitochondrial import-mediating protein in 1989 (Vestweber et al., 1989). 
Approximately a decade after translocation supercomplexes were observed, they were 
isolated and biochemically shown to consist of a tertiary complex of the precursor, TOM 
and TIM23 (Dekker et al., 1997; Sirrenberg et al., 1997). Today, we know that 
presequence-containing precursors of a particular size range are capable of translocase 
supercomplex formation when a stable fold is induced in the C-terminal portion of the 
substrate, preventing TOM passage (Dekker et al., 1997; Krayl et al., 2007). In fact, these 
translocase supercomplex intermediates are stable enough to survive digitonin 
solubilization and BN-PAGE and require a Δψ, ATP and a C-terminal stable fold 
(Chacinska et al., 2003; 2005; 2010). The absolute dependence on an intact Δψ for the 
isolation of a translocation supercomplex is due to the functional coupling of both TOM 
and TIM23 passage (Chacinska et al., 2010), therefore presenting a possible explanation, 
in a defined precursor subset, to the energetics predicament of OM passage by TOM. This 
model couples the energy requirements of IM translocation to the “pulling” of the substrate 
through the OM. However, it is known that for short precursors, less than ∼ 80 residues, a 
translocation supercomplex is not formed (Krayl et al., 2007), exemplifying our lack of 





1.3.2. Mitochondrial import of metabolite carrier proteins, the carrier pathway 
 Mitochondrial substrates targeted to the mitochondrial IM have two possible routes, 
the presequence pathway (see section 1.3.1. for a detailed description) and the carrier 
pathway (Fig. 4). Their common destination, the mitochondrial IM, is one of the most, if 
not the most, protein-rich membranes known (Dudek et al., 2013). This fact is certainly 
due to the energy production demands of the mitochondrial respiratory chain (see section 
1.2. for a description), fulfilling the majority of cellular energy needs in almost all human 
cell types. The term “carrier pathway” was coined due to the observation that multiple 
metabolites are transported across the mitochondrial IM through channels that share a 
common import and assembly pathway. The carrier pathway is utilized by proteins 
destined for the mitochondrial IM, lacking presequences and containing multiple 
transmembrane domains (Dudek et al., 2013). The structure of carrier proteins is best 
described by three pairs of membrane-spanning segments, each of which connected by a 
hydrophilic loop, with the even transmembrane domains forming salt bridges during each 
transport cycle (Ruprecht et al., 2014). This group of substrates is best exemplified by two 
well-characterized proteins, the ADP/ATP carrier (AAC) and the phosphate carrier (PiC); 




Figure 4. The mitochondrial carrier pathway. Substrates of the carrier pathway enter the 
mitochondrion through TOM in a Tom70 dependent manner. After entering the intermembrane space 
(IMS), small TIMs bind the hydrophobic substrate and shuttle it to the TIM22 complex via interaction 
with Tim12. The substrate is positioned via the receptor Tim54 and the transmembrane domains are 
inserted loop-wise into the inner membrane (IM) in a ∆ψ dependent manner. OM, outer membrane. 
 
 The import of carrier proteins into the mitochondrion has been characterized to 
exhibit five distinct and isolatable import stages (Pfanner et al., 1987; Ryan et al., 1999). 
During stage one, the highly hydrophobic nascent substrate is kept in a soluble state via the 
concerted activity of Hsp90 and Hsp70 in mammals (in yeast, Hsp70 alone is utilized) 
(Young et al., 2003; Zara et al., 2009; Zimmermann and Neupert, 1980). Following 
chaperone binding, stage two entails the substrate-chaperone complex being targeted to the 
outer mitochondrial membrane via chaperone interactions with the TOM complex receptor, 
a Tom70 dimer, utilizing its tricopeptide repeat (TPR) domains (Young et al., 2003). A 






















yeast [R171] to human [R192]) Tom70 residue mediates its interaction with substrate-
loaded chaperones. In a peptide scanning approach, Tom70 was found to exhibit affinity to 
several peptides of internal-targeting-signal containing carrier pathway substrates (Brix et 
al., 1997; 1999; 2000). Moreover, other studies have found strong evidence for the 
interaction of a single carrier substrate with three copies of a Tom70 dimer as the substrate 
is prepared for OM passage (Wiedemann et al., 2001). 
 Stage three of the carrier pathway is observed in in vitro import reactions under 
conditions in which the ∆ψ has been depleted and when ATP is exogenously added (Ryan 
et al., 1999). Stage three has been divided into two steps, the first of which involves the 
binding of the IMS chaperone Tim9-Tim10 heterohexamer complex when loops of the 
substrate transverse the OM through the TOM channel (Curran et al., 2002; Endres et al., 
1999; Koehler et al., 1998; Luciano et al., 2001; Sirrenberg et al., 1998). This chaperone-
like complex association with the translocating substrate allows for the release of the 
substrate from the trans side of the TOM complex (Truscott et al., 2002). Moreover, a 
homologous IMS chaperone complex, Tim8-Tim13, has been implicated in the 
translocation of Tim23 and therefore likely functions similarly to the Tim9-Tim10 
complex during the import of non-carrier proteins which utilize the carrier pathway for IM 
import and assembly (Beverly et al., 2008; Davis et al., 2007; Hoppins and Nargang, 
2004). The second step of stage three involves the association of Tim12, allowing for the 
small TIM bound translocation intermediate to interact with the translocase of the inner 
mitochondrial membrane (TIM22, carrier translocase) (Gebert et al., 2008; Sirrenberg et 
al., 1998). It was later noticed that the accumulation of the protease resistant stage three 
intermediate, seen in conditions with a depleted ∆ψ and exogenous ATP after BN-PAGE, 
represented the small TIM bound substrate tethered to the carrier translocase (Rehling et 
al., 2003).  
The TIM22 translocase was shown via electron microscopy (EM) to contain two 
pores, each capable of passing two α-helices simultaneously, formed by its pore-forming 
subunit Tim22 (Rehling et al., 2003). The carrier translocase is comprised of the central 
channel-forming subunit Tim22 and the assembly and receptor subunits Tim54, Tim18 and 
Sdh3 (Dudek et al., 2013). Tim54 consists of an extended IMS domain which has been 
shown to be the docking point for small TIM bound carrier translocase substrates (Hwang 
et al., 2007; Wagner et al., 2008). Tim18, an Sdh4 homolog of complex II (succinate 
dehydrogenase) of the respiratory chain, was observed to function as a Tim54 assembly 
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factor, assisting its integration into the TIM22 complex (Wagner et al., 2008). Sdh3, a 
subunit of the respiratory chain succinate dehydrogenase, was recently added to the list of 
TIM22 components as it forms a subcomplex with Tim18 during the assembly of the 
carrier translocase (Gebert et al., 2011). During stage four of carrier import, the twin-pore 
channel is opened in a ∆ψ and signal-dependent manner (Kovermann et al., 2002), at 
which point loops of the substrate are inserted into the IM, likely due to the electrophoretic 
force imparted on the positive charges in the loop regions by the ∆ψ. Stage five entails the 
lateral release of the substrate into the IM by a presently elusive mechanism and, in the 
case of metabolite carriers, subsequent homodimer formation (Dudek et al., 2013). 
 
1.3.3. Mitochondrial import and assembly of outer membrane β-barrel proteins 
 Gram-negative bacteria, a distant ancestor of modern day endosymbiotic 
organelles, are surrounded by two encompassing membrane envelopes. The bacterial outer 
envelope is residence to over 70 different β-barrel-type proteins (Wimley, 2003). A 
hallmark, retained uniquely within eukaryotic organelles of endosymbiotic origin, are β-
barrel OM proteins (Dolezal et al., 2006). Thus far, mitochondrial researchers have 
uncovered four β-barrel OM proteins (Tom40, Sam50, Mdm10 and porin [voltage-
dependent anion-selective channel, known as VDAC1 in humans]) which contain a distinct 
motif, known as the β-signal, and utilize a partially evolutionary conserved import and 
assembly pathway (Fig. 5) (Kutik et al., 2008). The established C-terminal OM import and 
assembly targeting motif (Polar, x, Glycine, x,x, Large hydrophobic, x, Large hydrophobic 
[x = any residue]) of these proteins commences at the main mitochondrial entry gate, TOM 
(Kutik et al., 2008). After being translated on cytosolic ribosomes, the β-barrel-type 
protein is inserted into the IMS via the TOM complex, utilizing all three major TOM 
receptors (Tom20, Tom22 and Tom70). Moreover, Tom40 (the pore-forming subunit of 
the TOM complex), has been shown to exhibit chaperone-like functions when 
translocating hydrophobic substrates (Esaki et al., 2003), likely preventing the aggregation 




Figure 5. The mitochondrial sorting and assembly (SAM) pathway. β-signal-containing substrates 
(β-barrel proteins of the outer membrane [OM]) are imported first via TOM through the actions of 
Tom70, Tom22 and Tom20. Upon entering the intermembrane space (IMS) they interact with the 
heterohexamer chaperone complex, known as the small TIMs, and are directly handed off to the 
sorting and assembly machinery (SAM). Through the actions of the SAM complex, the β-barrel 
substrate is inserted into the OM and assembled into its target complex. 
 
 When the β-signal-containing substrate enters the IMS, local chaperones (Tim9-
Tim10 heterohexamers) prevent aggregation in route to the sorting and assembly (SAM) of 
the OM (Webb et al., 2006; Wiedemann et al., 2004b). The SAM complex is conserved 
among eukaryotes and comprised of two essential core components Sam50 and Sam35, as 
well as Sam37 and Mdm10 (Chacinska et al., 2009; Dudek et al., 2013; Meisinger et al., 
2004; Waizenegger et al., 2004). Sam50 is a homolog of the bacterial Omp85 (BamA) and 
a β-barrel protein with channel conducting activity corresponding to a large pore diameter 
of 40 – 50 Å (Kutik et al., 2008). Sam50’s N-terminus contains a single polypeptide 
transport associated (POTRA) domain, as opposed to Omp85, which has five. In bacteria, 
the most C-terminal POTRA domain of Omp85 (retained in the mitochondrial homolog 
Sam50) was shown to be essential, as opposed to the N-terminal four which elicited only 
mild growth effects upon their deletion (Bos et al., 2007). In mitochondria, the POTRA 
domain of Sam50 was shown to bind specifically to β-barrel precursors, hinting on its 
receptor function (Habib et al., 2007). However, shortly after this finding, Kutik et al. 

















complex activity, uncovering Sam35 as the IMS facing β-signal receptor (Kutik et al., 
2008). In the study by Kutik and others, Sam35 was shown to act as a receptor and exhibit 
β-signal affinity, specifically when expressed and purified from E. coli. Sam37 (Mas37), 
initially identified as a TOM constituent (Wiedemann et al., 2003) (likely due to the recent 
discovery of the association of TOM and SAM [Qiu et al., 2013]), is now known to be the 
substituent of the SAM complex, involved in the release of substrates for the SAM 
complex (Chan and Lithgow, 2008). Mdm10, associated with both the SAM and the 
endoplasmic reticulum-mitochondria encounter structure (ERMES), is known to promote 
late stages of Tom40 assembly (Meisinger et al., 2004). 
 Moreover, recent investigation into the functionally elusive POTRA domain of 
Sam50 has brought to light its underlying evolutionary fitness-conferring role. Stroud et al. 
utilized a wheat germ lysate system to produce β-barrel substrates for use in subsequent 
import assays utilizing mitochondria which lacked the POTRA domain of Sam50 (Stroud 
et al., 2011). In their assay, they were able to stress the SAM complex with an abundance 
of incoming substrate, which allowed for the visualization of precursor accumulation 
within the SAM complex. This data then allowed for the assignment of a substrate release 
role of the highly evolutionary conserved POTRA domain of Sam50. 
 It should be noted that other β-barrel-type proteins have been characterized to 
reside in the outer mitochondrial membrane, such as Mmm2 (Mdm34) (Youngman et al., 
2004). Mmm2, an established ERMES component (Kornmann et al., 2009; Wideman et 
al., 2013), has a β-signal distal to the C-terminus (Imai et al., 2008), suggesting a divergent 
or slightly modified import and/or assembly mechanism exists for mitochondrial β-barrel 
OM proteins. 
 
1.3.4. Mitochondrial intermembrane space import and assembly pathway  
 The mitochondrial intermembrane space import and assembly (MIA) pathway is a 
key import pathway for substrates destined for the IMS that contain a defined multiple 
cysteine motif, CxnC (Fig. 6) (Milenkovic et al., 2009; Sideris et al., 2009). The core MIA 
machinery consists of the essential subunits Mia40 and Erv1 which are involved in the 
formation of transient disulfide bonds with incoming substrates and subsequently function 
in a disulfide relay system which is responsible for the both the assembly and retention of 
many IMS substrates (Allen et al., 2005; Chacinska et al., 2004; Grumbt et al., 2007; 
Mesecke et al., 2005; Milenkovic et al., 2007; Naoé et al., 2004). Mia40 engages with its 
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substrates at the trans side of the TOM channel, positioned by Fcj1 of the mitochondrial 
inner membrane organizing system (MINOS) (Malsburg et al., 2011), by forming 
intermolecular disulfide bonds in its redox-active cysteine – proline – cysteine motif 
hydrophobic groove (Banci et al., 2011; 2009; Kawano et al., 2009; Terziyska et al., 2009). 
Immediately following the intermolecular disulfide bond between Mia40 and its substrate, 
Mia40 catalyses intramolecular disulfide bridge formation within the substrate (Chacinska 
et al., 2004; Müller et al., 2008). This mode of disulfide bridge formation is now known to 
trigger the retention of various dual-localized proteins such as superoxide dismutase 1 and 
its copper chaperone Ccs1 (Gross et al., 2011; Kawamata and Manfredi, 2010; Klöppel et 
al., 2011; Reddehase et al., 2009), thereby instilling a key regulatory role within MIA 
pathway. 
 
Figure 6. The mitochondrial intermembrane space import and assembly (MIA) pathway. CxnC 
signal-containing substrates cross the outer membrane (OM) at TOM and are oxidized in the IMS via 
Mia40 and allowed to form intramolecular disulfide bridges and proceed to the small TIMs for final 
folding. Erv1 associates with Mia40 in complex with a substrate and allows for the reoxidation of 
Mia40. 
 
 Following the catalysis of the substrate intramolecular disulfide bridge by Mia40, 
its reoxidation is carried out by Erv1 (Bien et al., 2010; Dabir et al., 2007). Erv1 has been 



















al., 2008), streamlining the Mia40 import cycle. The active Erv1 homodimer shuttles 
electrons from Mia40 to molecular oxygen via cytochrome c and cytochrome c oxidase of 
the respiratory chain (Banci et al., 2011; Bihlmaier et al., 2007; Mesecke et al., 2005). 
Thus, the coupling of the MIA disulfide relay system to the respiratory chain ensures the 
maintenance of oxidized Mia40, thereby allowing for continuous import rounds and the 
suppression of toxic reactive oxygen species (ROS). The now intramolecular disulfide 
bridge containing substrate then can interact with the chaperone acting small TIMs of the 
IMS, allowing for proper folding to take place and subsequent release of the soluble 
protein (Chacinska et al., 2009). 
 
1.3.5. Mitochondrial import of α-helical outer membrane proteins 
 The sorting of α-helical OM proteins containing either an N-terminal anchor 
sequence (Becker et al., 2008; Hulett et al., 2008) or, in some cases, multiple 
transmambrane domains (Becker et al., 2011; Papic et al., 2011) is carried out by the Mim1 
complex (Fig. 7). Mim1, originally identified to be involved in assembly of β-barrel OM 
proteins (Ishikawa et al., 2004), has been recently shown to mediate the OM integration of 
α-helical, single and multiple transmembrane-containing proteins (Becker et al., 2011; 
2008; 2010; Hulett et al., 2008; Lueder and Lithgow, 2009; Papic et al., 2011; Popov-
Celeketić et al., 2008b; Thornton et al., 2010). Moreover, Tom70 has been implicated in 
the Mim1 import pathway, serving as a receptor for incoming substrates and being a Mim1 
substrate itself (Becker et al., 2011; 2008). Therefore, the Mim1 complex has been firmly 
established to play a crucial role in the OM integration of many α-helical proteins. In 
particular the biogenesis of the translocase of the outer mitochondrial membrane (TOM) 
complex as Tom5, Tom6, Tom7, Tom20 and Tom70 require Mim1 for efficient OM 
integration (Becker et al., 2008; Hulett et al., 2008). Following the identification of 
Mim1’s intimate role in the OM integration of the majority of TOM proteins, the original 
finding of its role in β-barrel sorting was shown to be the result of an indirect effect 
(Becker et al., 2010), as Tom40 (a β-barrel protein consisting of the pore-forming TOM 
subunit) is known to display assembly defects in the absence of the small TOM subunits 
(Tom5, Tom6 and Tom7) (Alconada et al., 1995; Dekker et al., 1998; Dembowski et al., 
2001; Dietmeier et al., 1997; Hönlinger et al., 1996; Kato and Mihara, 2008; Schmitt et al., 
2005; Sherman et al., 2005). 
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Figure 7. The import of mitochondrial α-helical outer membrane (OM) proteins. Single and 
multiple transmembrane domain containing α-helical OM proteins, containing an N- or C-terminal 
anchor, are integrated into the OM via the Mim1 complex in a Tom70 dependent manner. 
 
Finally, the last variant of α-helical OM proteins, single transmembrane domain 
containing C-terminally anchored proteins, appear to be integrated into the mitochondrial 
OM without a proteinaceous integration machinery (with the exception of Tom22) 
(Kemper et al., 2008; Setoguchi et al., 2006). Kemper et al., utilizing the model single 
transmembrane containing C-terminally anchored α-helical OM protein Fis1, observed that 
a large number of characterized OM translocation mutants had no impact on Fis1 
integration and that Fis1 was able to efficiently integrate in lipid vesicles (Kemper et al., 
2008). Moreover, they observed vesicular ergosterol content to negatively impact 
membrane integration of Fis1, hinting on a non-proteinaceous lipid regulated import 
system. In conclusion, there appear to be multiple avenues for the insertion of α-helical 
OM proteins, segregated by a combination of the position of the anchor sequence and the 














1.4. Research objectives 
 This work aims to advance our understanding of mitochondrial OM passage of 
presequence-containing substrates. In brief, our current knowledge of presequence 
translocation at the TOM complex is lacking a step-by-step delineation of presequence 
interactions at the OM, leading to presequence engagement with IM bound presequence 
receptors. Presently, a wealth of information exists in regard to the presequences’ 
interaction with cytosolically-oriented TOM receptors. However, in stark contrast, very 
little is known about the mechanistic steps made by the presequence-containing precursor 
after it has been handed over to the pore-forming subunit of the TOM complex, Tom40. 
Moreover, the lone trans-acting presequence receptor, the IMS domain of Tom22, was 
shown to exhibit a remarkably insignificant impact on presequence mediated import 
(Frazier et al., 2003; Moczko et al., 1997), yet no other TOM presequence-interacting site 
has been characterized downstream of the cytosolically exposed receptors. This gap in OM 
translocation understanding is strongly preventing the establishment of a general functional 
TOM model. This predicament is highlighted by the utter lack of understanding as to 
where substrates pass the OM, specifically if the Tom40 pore is directly used or if the 
formation of higher ordered TOMCORE (consisting of Tom40 and Tom22) structures allow 
for channel formation within the OM, an idea previously suggested, which allows for the 
lateral release of TOM substrates (Harner et al., 2011). A more complete understanding of 
the sequential steps taken by the presequence-containing substrate, particularly the 
interactions within the Tom40 pore, would allow for the more accurate interpretation of 
future thought-provoking OM passage observations. Here, an in-depth structural and 
functional examination of Tom40 presequence interactions is undertaken with the aims of 
better understanding presequence mediated TOM passage. 
 The second objective of the present work examines the steps in presequence 
transport immediately following TOM mediated OM passage, described above. After the 
presequence-containing substrate exits the TOM channel, it must be recognized and 
brought to the presequence translocase. At the presequence translocase, IMS exposed 
domains of its constituents must sense the incoming substrate and then trigger dynamic 
translocase rearrangements in response to the intended destination of the substrate, lateral 
release into the IM or translocation into the matrix by way of the associated PAM 
complex. This process of translocase priming due to an incoming substrate is presently not 
fully understood, however, numerous publications have demonstrated the dynamic nature 
of TIM23 subunits, specifically Tim21 and Tim50 (Chacinska et al., 2005; Mokranjac et 
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al., 2005; Schulz et al., 2011). The present investigation seeks to advance upon the 
previously published knowledge of TIM23 dynamics and attempts to link presequence 
presentation in the IMS with the sequence of events that takes place at the presequence 
translocase during the early translocation priming stages. 
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 All commonly used chemicals were purchased from the following companies; 
AppliChem (Darmstadt, Germany), Roth (Karlsruhe, Germany), Sigma-Aldrich 
(Taufkirchen, Germany), Merck (Darmstadt, Germany) and SERVA (Heidelberg, 
Germany). All chemicals obtained from the aforementioned companies were of analytical 
grade. Chemicals considered non-standard are listed in Table 1 along with the 
corresponding producer. 
 








BSA (fatty acid free) Sigma Aldrich 
CNBr-Activated Sepharose 4B GE-Healthcare 
Coomassie brilliant blue G250/R250 Serva 
Complete EDTA free protease inhibitor Roche 
Creatine phosphate Roche 
Digitonin Calbiochem 
Dimethyl pimelimidate (DMP) Sigma Aldrich 
Dropout mixes; CSM-Trp, CSM-URA MP Biomedicals 
Enhanced chemiluminescence detection reagent GE-Healthcare, Millipore, 
Pierce/Thermo Scientific  
5-Fluoroorotic acid (5-FOA) Fermentas 
GeneRuler DNA Ladder Mix Fermentas  
Herring sperm DNA Promega 
High molecular weight calibration kit GE-Healthcare 
IgG protein standard (bovine) Biorad 
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Leupeptine Sigma Aldrich 
NADH Roche 
Ni-NTA agarose Qiagen 




Peptone, yeast extract and yeast nitrogen base w/o AAs BD 




SDS marker Serva 
[35S]Methionine Hartmann Analytics 
Streptavidin horseradish peroxidase (SA-HRP) Dianova 




 All consumables used in this study are listed in Table 2, along with their respective 
producers. 
 
Table 2.  List of consumables used in this study, together with producers. 
Consumable Producer 
 
CELL STAR® centrifuge tubes 15ml and 50ml 
 
Greiner 
Centrifugal filters  Millipore 
Medical x-ray films Foma 
Micro tube 1.5 ml and 2.0 ml Sarstadt 
Minisart® syringe filters Sartorius  
Mobicol spin columns MoBiTec 
PD G10 desalting columns GE-Healthcare 
Pipette tips Sarstadt 
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Polyvinylidene fluoride (PVDF) Membrane Millipore 
SnakeSkin dialysis tubing 7k MWCO Thermo Scientific 
 
2.1.3. Kits 
 All Kits used in this work are listed in Table 3 with their suppler. All listed kits 
were used according to the manufactures’ instructions. 
 
Table 3.  List of kits and suppliers used in this work. 
Kit Suppler 
 
KOD Hot Start DNA polymerase 
 
Novagen 
mMESSAGE mMACHINE® SP6 Kit Ambion 
QuikChange® Lightning site-directed mutagenesis Stratagene/Agilent 
TNT® Quick coupled Transcription/Translation system Promega 
Wizard® Plus SV Minipreps DNA Purification system Promega 
Wizard® SV Gel and PCR Clean-up system Promega 
 
2.1.4. Enzymes 
 All enzymes used in this work are listed in Table 4, in addition to the 
corresponding manufacturer. 
 






DNase I Roche 
Trypsin Sigma Aldrich 
Proteinase K Roche 







 The peptides, corresponding sequences and producers are listed in Table 5. 
Purchased peptides were synthesized as an N-terminal amine and a C-terminal amide. 
When the peptide was self-synthesized a corresponding reference is listed. 
 
Table 5.  List of peptides, sequences and producers/literature reference. 






JPT Peptide Technologies 
Synb2 MLSRQQSQRQSRQQSQRQSRYLL JPT Peptide Technologies 
(Allison and Schatz, 1986) 
pCox4 MLSLRQSIRFFKPATRTLSSSRYLL  JPT Peptide Technologies 
(Allison and Schatz, 1986) 
pL19B MLRAALSTARRGPRLSRLBpaSAAARKbioHH
HHHH 
(Schulz et al., 2011) 
pS16B MLRAALSTARRGPRLBpaRLLSAAARKbioHH
HHHH 
(Schulz et al., 2011) 
 
2.1.6. Antibodies 
 All primary antibodies directed against yeast and mouse proteins were produced 
though antigen injection into rabbits and are listed in Table 6. Antigens were either in the 
form of a purified recombinant protein or a synthesized peptide. HA antibody was obtained 
from 12CA5 hybridoma supernatant. Secondary antibodies for use in Western blot 
detection, goat anti rabbit HRP and goat anti rabbit IR680 were purchased from Dianova 
(Hamburg, Germany) and LI-COR (Bad Homburg, Germany), respectively. 
 
Table 6.  List of primary antibodies and corresponding epitopes used in this 
study. 




Peptide: sequence not available 
 
AG Rehling #945 
Atp5 Peptide: CDLSISTKIQKLNKVLEDSI AG Rehling #1546 
Atp20 Peptide: CSVGEIIGRRKLVGYKHH AG Rehling #1517 
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HA YPYDVPDYA Mouse monoclonal 12CA5 
Mcr1 Whole protein AG Pfanner #613 
mDHFR Peptide: EEKGIKYKFEVYEKKD AG Rehling #1846 
Mdm38 Peptide: IPADQAAKTFVIKKD AG Rehling #342 
Pam17 Information not available  AG Rehling #279 
Por1 Information not available AG Rehling #B94-E 
Rip1 Peptide: LEIPAYEFDGDKVIVG AG Rehling #543 
Ssc1 Whole protein AG Rehling #119 
Tim17 Peptide: PLPEAPSSQPLQA AG Rehling #302 
Tim21 IMS domain AG Rehling #3111 
Tim23 IMS domain AG Rehling #3845 
Tim44 Peptide: EGWKILEFVRGGSRQFT AG Rehling #127 
Tim50 IMS domain AG Rehling #3314 
Tom5 Peptide: MFGLPQQEVSEEEKRAC AG Rehling #3635 
Tom20 Cytosolic domain AG Rehling #3534 
Tom22 Cytosolic domain AG Rehling #3533 
Tom40 Whole protein AG Rehling #4901 
Tom70 Cytosolic domain AG Rehling #3530 
 
2.1.7. Plasmids 
 The plasmids used in this study are listed in Table 7, along with the originating 
vector, insert and relevant reference. 
 
Table 7.  List of plasmids used in this study. 






N. crassa AAC 
 
(Steger et al., 1990) 
B07 pUHE 73-1 b2 (167)Δ-DHFR (Koll et al., 1992) 
pAF1 pGEM4Z OXA1 (Frazier et al., 2003) 
pYM10 pYM10 HIS3MX6 (Janke et al., 2004) 
Tim9 pGEM4Z TIM9 (Wrobel et al., 2013) 
Tom40-Ura pFL39 (Ura) TOM40 (Kutik et al., 2008) 
Tom40-Trp pFL39 (Trp) TOM40 (Kutik et al., 2008) 
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tom40E mut pFL39 (Trp) tom40E mut This study 
tom40V mut pFL39 (Trp) tom40V mut This study 
' pFL39 (Trp) ' (Bonneaud et al., 
1991) 
Tim21IMS pProExHTa tim21IMS (Albrecht et al., 
2006) 
Tim23IMS pET10C tim23IMS (Truscott et al., 
2001) 
Tim23YL70AA pET10C tim23IMS-YL70AA (Lytovchenko et al., 
2013) 
Tim50IMS pProExHTc tim50IMS (Schulz et al., 2011) 
 
2.1.8. Yeast Strains 
 Yeast strains utilize in this work, along with the corresponding genotypes and 
relevant references are listed in Table 8. 
 
Table 8.  List of yeast strains used in this study. 




MATa, ade2-101, his3-Δ200, leu2-Δ1, ura3-52, 
trp1-Δ63, lys2-801 
 
(Sikorski and Hieter, 
1989) 
tim21Δ MATa, ade2-101, his3-Δ200, leu2-Δ1, ura3-52, 
trp1-Δ63, lys2-801; tim21::HIS3MX6 
(Chacinska et al., 
2005) 
Tim21ProtA MATa, ade2-101, his3-Δ200, leu2-Δ1, ura3-52, 
trp1-Δ63, lys2-801; tim21::TIM21ProtA-HIS3MX6 
(Chacinska et al., 
2005) 
TOM40Δ MATa, ade2-101, his3-Δ200, leu2-Δ1, ura3-52, 
trp1-Δ63, lys2-801; tom40::ADE2; [pFL39URA3-
TOM40] 
(Kutik et al., 2008) 
TOM40 MATa, ade2-101, his3-Δ200, leu2-Δ1, ura3-52, 
trp1-Δ63, lys2-801; tom40::ADE2; [pFL39TRP1-
TOM40] 
(Kutik et al., 2008) 
tom40E mut MATa, ade2-101, his3-Δ200, leu2-Δ1, ura3-52, 
trp1-Δ63, lys2-801; tom40::ADE2; [pFL39TRP1-
tom40E mut] 
This study 
tom40V mut MATa, ade2-101, his3-Δ200, leu2-Δ1, ura3-52, 






MATa, ade2-101, his3-Δ200, leu2-Δ1, ura3-52, 





MATa, ade2-101, his3-Δ200 leu2-Δ1, ura3-52, 
trp1-Δ63, lys2-801; tom40::ADE2; tom22-




MATa, ade2-101, his3-Δ200, leu2-Δ1, ura3-52, 
trp1-Δ63, lys2-801; tom40::ADE2; tom22-
2::HIS3MX6 [pFL39TRP1-tom40V mut] 
This study 
yCS2 MATa, ade2-101, his3-Δ200, leu2-Δ1, ura3-52, 
trp1-Δ63, lys2-801, tim50::HIS3-PGAL1-TIM50 
[pCS27] 
(Schulz et al., 2011) 
yCS3 MATa, ade2-101, his3-Δ200, leu2-Δ1, ura3-52, 
trp1-Δ63, lys2-801, tim50::HIS3-PGAL1-TIM50 
[pCS26] 
(Schulz et al., 2011) 
 
2.1.9. Laboratory Equipment 
 This study was performed using the laboratory equipment listed in Table 9. 
 
Table 9.  List of laboratory equipment used throughout the study, along with 
the corresponding suppler. 
Product Supplier 
 
Centrifuges and Rotors 
Centrifuge 5417R Eppendorf 
Centrifuge 5424 Eppendorf 
Centrifuge 5804R Eppendorf 
Rotor F45-30-11  Eppendorf 
Rotor F45-24-11  Eppendorf 
Rotor A-4-44 Eppendorf 
Sorvall® RC 6TM Plus Superspeed Centrifuge Thermo Scientific 
Sorvall® RC12BPTM Low-Speed Centrifuge Thermo Scientific 
Sorwall H-12000 Thermo Scientific 
Rotor Sorwall F14S-6x250Y Thermo Scientific 
Rotor Sorwall F10S-6x500Y Thermo Scientific 




Electrophoresis and Blotting 
EPS 601 power supply GE-Healthcare 
Hoefer SE600 Ruby Blue native system GE-Healthcare 
Mini-PROTEAN® 3 Cell Bio-Rad 
Mini-Sub® Cell GT Cell Bio-Rad 
PowerPacTM HC Power Supply Bio-Rad 
Semi Dry Blotting chamber PEQLAB Biotechnologie 
 
FPLC Equipment 
ÄKTA Purifier 10 GE-Healthcare 
HiLoad 16/60 Superdex 75 GE-Healthcare 
HisTrap HP, 1 ml and 5 ml GE-Healthcare 
ResourceTM S 1 ml GE-Healthcare 
 
Imagining Equipment 
Agfa Curix 60 Developing machine AGFA 
Autoradiography storage phosphor screen GE-Healthcare 
LAS 3000 FujiFilm 
Starion FLA-9000 FujiFilm 
Storm 820 phosphorimager GE-Healthcare 
UVsolo TS transilluminator Biometra 
 
Miscellaneous 
Autoclave Systec DX-200 Systec 
Balance BP 3100P Sartorius 
Electronic Digital Balance Kern ABJ 220-4M KERN & Sohn 
EmulsiFlex C5 Avestin 
Excella® E10 platform shaker New Brunswick Scientific 
G 25 Shaker Incubator New Brunswick Scientific 
iMarkTM Microplate Absorbance Reader Bio-Rad 
Innova® 44 Incubator Shaker New Brunswick Scientific 
GeneQuantTM 1300 Spectrophotometer GE-Healthcare 
Magnetic stirrer MR 3001 Heidolph 
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Milli-Q-water purification system Millipore 
NanoVueTM Spectrophotometer GE-Healthcare 
pH-meter inoLab 
Pipettes Gilson 
Potter S Homogenizer Sartorius 
SpeedVac concentrator Savant 
Thermomixer Comfort Eppendorf 
TPersonal 48 thermocycler Biometra 
Vortex-Genie 2 Scientific Industries 
 
2.1.10. Software 
 All software used throughout the course of the study is listed in Table 10. 
 
Table 10.  List of software used in the study, along with the corresponding use 
and developer. 
Software Use Developer 
 





Adobe Photoshop CS4 Image processing Adobe 
DataGraph Graphing Visual Data Tools 
Geneious Pro 4.8.3 In silico cloning and mutagenesis Biomatters Ltd. 
HHpred Protein homolog detection (Soding et al., 2005) 
ImageQuant TL v 7.0 Quantification GE-Healthcare 
MODELLER Homology modeling (Soding et al., 2005) 




2.1.11. Buffers, Solutions and Media 
 All buffers, solutions and culture media used in this work are listed in Table 11 





Table 11. List of buffers and solutions together with their respective 
composition. 
Buffer or Solution Composition 
Acetate buffer 0.5 M NH4CH3COOH/CH3COOH pH 3.4 
AVO 1 mM antimycin A, 0.1 mM valinomycin, 2 mM oligomycin 
b2 lysis buffer 20 mM MOPS/KOH pH 8.0, 1 mM EDTA, 10 mM 
dithiothreitol, 0.1% Triton X-100, 1 mM PMSF and Complete 
EDTA-free protease inhibitor (Roche)  
b2 buffer A 20 mM MOPS/KOH pH 8.0, 1 mM EDTA 
 
b2 buffer B 20 mM MOPS/KOH pH 8.0, 1 mM EDTA, 500 mM NaCl 
Blotting buffer 20 mM Tris, 0.02% SDS, 150 mM glycine, 20% ethanol 
BN acrylamide solution 48% acrylamide, 1,5% bisacrylamide (32:1) 
BN Anode buffer 50 mM Bis-Tris/HCl pH 7.0 
BN Cathode buffer 50 mM tricine, 15 mM Bis-Tris/HCl, with or without 0.02% 
Coomassie Brilliant Blue G250 
BN gel buffer (3x) 200 mM 6-aminohaxanoic acid, 150 mM Bis-Tris/HCl pH 7.0 
BN sample buffer (10x) 5% Coomassie brilliant blue G250, 500 mM 6-aminohaxanoic 
acid, 100 mM Bis-Tris/HCl pH 7.0 
Carrier DNA Herring sperm DNA (10 mg/ml) in TE buffer 
CNBr Coupling buffer 100 mM NaHCO3 pH 8.3, 500 mM NaCl 
Colloidal Coomassie 
fixer 
50% methanol, 2% phosphoric acid 
Colloidal Coomassie 
stainer 
0.1% Coomassie Brilliant Blue G250, 2 % phosphoric acid, 10% 
ammonium sulfate, 20% methanol 
Coomassie destainer 40% ethanol, 10% acetic acid 
Coomassie stainer 40% ethanol, 10% acetic acid, 0.5% Coomassie Brilliant Blue 
R250 
CSM 0.67% yeast nitrogen base, 0.07% complete synthetic mixture 
Digitonin buffer 20 mM Tris/HCl pH 7.4, 80 mM NaCl, 10% glycerol, 0.5 mM 
EDTA, 2 mM PMSF, 1% digitonin 
Digitonin wash buffer 20 mM Tris/HCl pH 7.4, 80 mM NaCl, 10% glycerol, 5 mM 
EDTA, 2 mM PMSF, 0.3% digitonin 
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DNA loading dye 10% sucrose, 0.25% OrangeG  
DTT buffer 10 mM DTT, 100 mM Tris/H2SO4 pH 9.4 
5-FOA plates CSM media, 5.2 mM 5-FOA, 450 µM uracil, 2% sucrose, 2% 
agar 
Glycine elution buffer 100 mM glycine/HCl pH 2.5 
Homogenization buffer 0.6 M sorbitol, 10 mM Tris/HCl pH 7.4, 1 mM EDTA, 0.2% 
fatty acid free BSA, 1 mM PMSF 
Import buffer 3% BSA, 250 mM sucrose, 80 mM KCl, 5 mM MgCl2, 2 mM 
KH2PO4, 5 mM methionine, 10 mM MOPS/KOH pH 7.2, 2 
mM ATP, 2 mM NADH, with or without 100 µg/ml creatine 
kinase and 5 mM creatine phosphate 
LB 1% tryptone, 0.5% yeast extract, 1% NaCl 
LiAc/PEG 0.1 M lithium acetate, 40% polyethylene glycol 4000 
Protein loading buffer 10% glycerol, 2% SDS, 0.01% Bromphenol blue, 1% β-
mercaptoethanol, 20 mM Tris/HCl pH 6.8 
In vitro pull-down 
binding buffer 
20 mM HEPES/KOH pH 7.4, 100 mM KH2PO4, 10 mM 
Mg(C2H3O2)2, 10% glycerol, 0.5% Triton X-100 
Resolving buffer (5x) 1.87 M Tris/HCl pH 8.8 
Rf1 buffer 100 mM RbCl, 50 mM MnCl2•4H2O, 30 mM CH3CO2K/C2H4O2 
pH 5.8, 10 mM CaCl2•2H2O, 15% glycerol 
Rf2 buffer 10 mM RbCl, 10 mM MOPS/NaOH pH 6.8, 75 mM 
CaCl2•2H2O, 15% glycerol 
Running buffer 25 mM Tris, 192 mM glycine, 0.1% SDS 
SEM 250 mM sucrose, 1 mM EDTA, 10 mM MOPS/KOH pH 7.4 
SH buffer 0.6 M sorbitol, 20 mM HEPES/NaOH pH 7.2 
Stacking buffer (10x) 0.8 M Tris/HCl pH 6.8 
TAE buffer 40 mM Tris-acetate pH 8.0, 2 mM EDTA 
TBS-T 20 mM Tris/HCl pH 7.5, 125 mM NaCl, 0.1% Tween20 
TE 10 mM Tris/HCl pH 8.0, 1 mM EDTA 
Tim21IMS/Tim23IMS 
lysis buffer 
50 mM Na2HPO4 pH 8.0, 300 mM NaCl, 5 mM Imidazole, 










50 mM Na2HPO4 pH 8.0, 300 mM NaCl, 500 mM Imidazole 
Tim21IMS/Tim23IMS 
dialysis buffer 
20 mM HEPES/NaOH pH 7.2, 100 mM NaCl 
Tim50IMS lysis buffer 20 mM Tris/HCl pH 8.0, 500 mM NaCl, 15 mM imidazole, 
0.1% Triton X-100, 1 mM PMSF 
Tim50IMS buffer A 20 mM Tris/HCl pH 8.0, 500 mM NaCl, 15 mM imidazole 
Tim50IMS buffer B 20 mM Tris/HCl pH 8.0, 500 mM NaCl, 500 mM imidazole 
Tim50IMS dialysis 
buffer  
20 mM Tris/HCl pH 8.0, 500 mM NaCl 
Tom22 IP 
solubilization buffer 
20 mM Tris/HCl pH 7.4, 150 mM NaCl, 10% glycerol, 0.1 mM 
EDTA, 1% digitonin, 2 mM pefablock, 2 µg/ml leupeptin and 2 
mM PMSF 
Tom22His solubilization 
buffer (small scale) 
20 mM Tris/HCl pH 7.4, 100 mM NaCl, 10% glycerol, 0.1 mM 
EDTA, 30 mM imidazole, 1% digitonin and 1 mM PMSF 
Tom22His solubilization 
buffer (large scale) 
50 mM potassium acetate, 10 mM MOPS/KCl pH 7.0,!20% 
glycerol, 1% digitonin and 1 mM PMSF 
YP 1% yeast extract, 2% peptone 
2x YPAD 2% yeast extract, 4% peptone, 4% glucose, 0.008% adenine 
hemisulphate 
Zymolyase buffer 1.2 M sorbitol, 20 mM KH2PO4 pH 7.4 
 
 
2.2. E. coli manipulation 
 
2.2.1. Preparation of chemically competent E. coli 
 XL1-Blue and BL21 (Stratagene) E. coli strains were initially grown overnight in 
LB media at 37°C with vigorous shaking after inoculation from cryo-stock (20% glycerol 
at -80°C). The cells were made competent via the RbCl method according to the following 
protocol. Cells from the overnight culture were used to inoculate a fresh culture to 1:500 
and cells were returned to 37°C under aeration till an OD600 value of 0.5 was reached. At 
that point, cells were chilled on ice for 15 min and centrifuged at 1,000 xg for 10 min at 
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4°C. After centrifugation, the supernatant was removed and pre-cooled Rf1 buffer was 
used to resuspend the cell pellet, after which the cells were incubated on ice for 15 min. 
Next, the cells were again pelleted as previously stated and then resuspended in pre-cooled 
Rf2 buffer, prior to aliquoting and flash freezing in liquid N2. After which, the cells were 
stored at -80°C until use. 
 
2.2.2. Transformation of chemically competent E. coli 
 Chemically competent E. coli (either XL1-Blue or BL21 [Stratagene]) were 
removed from -80°C and thawed gently on ice. Subsequently, 50 – 200 ng of plasmid 
DNA was added and the mixture as incubated for 10 min on ice. Following incubation, the 
cell mixture was heat shocked for 45 seconds at 42°C under gentle agitation. After heat 
shock, cells were left to recover for 2 min on ice and then ample LB media was added to 
the container. Cells in LB media were then shifted to 37°C and grown for 1 hr under strong 
agitation. After the 37°C incubation, cells were pelleted lightly at 1,000 xg and plated on 
solid LB media (LB plus 1.5% agar) containing ampicillin 100 mg/ml and grown at 37°C 
until single colony selection was possible. 
 
2.3. Molecular Biology 
 
2.3.1.  Plasmid isolation from XL-1 Blue E. coli 
 Approximately 8 ml of an overnight XL-1 Blue culture was pelleted and subjected 
to DNA isolation using the Wizard® Plus SV Minipreps DNA Purification system 
(Promega) according to the manufacture’s instructions. Isolated DNA was quantified using 
a NanoVue spectrophotometer (GE-Healthcare), monitoring the absorbance at 260 nm. 
DNA was then frozen at -20°C until use. 
 
2.3.2. Polymerase chain reaction (PCR) 
 DNA amplification via PCR was performed using a KOD Hot Start DNA 
polymerase kit (Novagen) according to the manufactures instructions. Each reaction 
contained 100 – 200 ng of template DNA, 1.5 mM MgSO4, 0.2 mM dNTP mix, 0.3 µM 
forward and reverse primers, 1 x KOD buffer and 0.02 units/µl KOD polymerase. The 
PCR cycling program was as follows: 2 min KOD activation 95°C, followed by 35 cycles 
of denaturation for 20 sec at 95°C, annealing for 10 sec at the lowest primer melting 
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temperature and elongation for 20 sec each kb of product. After the cycling iterations were 
complete, the reaction was subjected to agarose gel electrophoresis with ethidium bromide 
staining. For the creation of the integration cassette used to create the tom22-2 allele 
(Frazier et al., 2003), the following primers were used with pYM10 as the template: 
AEF44 (5’ – GAC CAC CAC TGC TTT GTT ACT CGG TGT GCC ACT ATC CTT ATC 
TAT ACT TGC CGA ACA ATA GGG CGC GCC ACT TCT A – 3’) and AEF45 (5’ –
 CAT GTA TGG CTC CTT TTC TAA AAC CCT CTC TTT TCT TTT ACA TCA TTA 
AAA TTA ATG GCA TCG ATG AAT TCG AGC TCG – 3’). 
 
2.3.3. Agarose gel electrophoresis 
 Separation of DNA was achieved via agarose gel electrophoresis. Agarose gels 
were prepared by dissolving 1% agarose in TAE buffer, to which 1 µg/ml ethidium 
bromide was added, prior to gel casting. After DNA was mixed with the DNA loading dye, 
the gel was run at 8 V/cm in a MINI$Sub® Cell GT Cell (Bio$Rad) filled with TAE buffer. 
Following the gel run, fragments were visualized through the use of a UVsolo TS 
transilluminator (Biometra). If the downstream application required, the approprate DNA 
band was excised from the gel for subsequent isolation using the Wizard® SV Gel and 
PCR Clean-up system (Promega) according to the manufacture’s instructions.  
 
2.3.4. Site-directed mutagenesis 
 Site-directed mutagenesis was preformed using the QuikChange® Lightning kit 
(Stratagene) according to the manufacture’s instructions in order to create the point 
mutants needed for the study. The following primers were used: Tom40T220E JM26 (5’ –
 ATACTCCAGAGAAGACGGTAGCGCTCCAG – 3’) and JM27 (5’ –
 TACCGTCTTCTCTGGAGTATAAAGTTTCTA – 3’); Tom40T220V JM28 (5’ –
 ATACTCCAGAGTTGACGGTAGCGCTCCAG – 3’) and JM29 (5’ –
 TACCGTCAACTCTGGAGTATAAAGTTTCTA – 3’). 50 ng of template DNA (Tom40-
Trp) was mixed with 125 ng of each primer pair in the 50 µl reaction as specified in the 
manufacture’s instructions. The reaction was performed with the following steps: 
polymerase activation at 95°C for 30 sec and 20 cycles (95°C for 30 sec, 1 min primer 
annealing at 48°C and 6 min extension at 68°C). After completion, 2 µl of Dpn1 was 
added to the reaction and incubated for 1 hr at 37°C in order to digest the non-methylated 
template DNA. Subsequently, 12 µl of the reaction was added to 50 µl of the supplied ultra 
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competent XL-1 Blue cells and the transformation was performed according to the 
manufacture’s instructions. Following transformation, all cells were plated on solid LB 
media containing ampicillin as stated in section 2.2.2. and DNA was isolated from a single 
colony as specified in section 2.3.1. 
 
2.3.5. Sequencing of DNA constructs 
 DNA constructs were sent to GATC Biotech (Cologne) where the sequencing 
reaction was performed, followed by sequencing using a Sanger ABI 3730xl platform. 
After receipt of the sequencing data file, the sequencing reads were analyzed through the 
use of Geneious Pro 5.3.6 (Kearse et al., 2012). 
 
2.3.6. Peptide synthesis 
 Presequence probes were synthesized identically to the previously published 
protocol (Schulz et al., 2011), through the use of a peptide synthesizer (Applied 
Biosystems) via standard fluorenylmethoxycarbonyl chemistry. The UV activatable amino 
acid derivative para-benzoyl-Phe-OH (BPA [Bachem]) was added to the polypeptide chain 
through the use of an Fmoc derivative, and the biotin tag was introduced through the use of 
a biotinylated Lys residue. Following synthesis completion, peptides were severed from 
their resin and deprotected with 95% TFA, 2.5% triisopropylsilane and 2.5% H2O for 4 hr 
at room temperature. Peptides removed from the resin were characterized via reversed-
phase HPLC and mass spectrometry. N-terminal amine and C-terminal amide pCox4 and 
Synb2 were purchased from JPT Peptide Technologies. All peptides were resuspended in 
10 mM acetic acid, aliquoted and stored at -20°C until use. 
 
2.4. S. cerevisiae methods 
 
2.4.1. S. cerevisiae growth conditions 
 S. cerevisiae were grown in both liquid and solid (addition of 2% agar) YP media 
supplemented with 3% glycerol unless plasmid selection was required. When YP media 
was used, it was set to pH 5.8 with HCl before being autoclaved. In these cases, CSM 
media (lacking the appropriate component[s]) supplemented with 2% sucrose was utilized. 
Long-term storage of yeast was done at -80°C in media containing 2xYPAD and 20% 
glycerol.  
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Dilution growth tests on solid media were performed via OD600 normalization of an 
overnight YP culture, supplemented with 3% glycerol. Cells were spotted on plates 
containing YP media containing 3% glycerol in 10 fold serial dilutions and grown for three 
days at the specified temperature, at which point an image of the plate was captured with 
an LAS 3000. 
 
2.4.2.  5-FOA plasmid shuffling  
 S. cerevisiae containing multiple plasmids, encoding selection markers URA3 and 
TRP1, were first grown on CSM plates lacking both uracil and tryptophan containing 2% 
sucrose. Shuffling was achieved through plating on 5-FOA containing solid media, which 
were shielded from light at 30°C for three days. After initial plasmid selection, yeast were 
applied to an additional round of 5-FOA based plasmid selection before being placed back 
on plates containing YP supplemented with 3% glycerol. 
 
2.4.3.  Transformation of S. cerevisiae 
 Transformation of either plasmids or integration cassettes was done using the 
lithium acetate/PEG method previously established (Gietz and Schiestl, 2007), with subtle 
modifications. The appropriate yeast strain was grown overnight in 2xYPAD media and 
then reinoculated the following morning to an OD600 reading of 0.25. After the culture 
reached an OD600 reading of 2, the cells were pelleted via centrifugation at 3,000 xg for 10 
min. Subsequently, cells were washed with sterile water and then resuspended in 0.1M 
lithium acetate. Following lithium acetate incubation, cells were either aliquoted and 
frozen at -80°C or the transformation protocol was continued. 120 µg of herring sperm 
DNA was denatured at 95°C for 5 min and rapidly cooled on ice, then added to 100 µl of 
lithium acetate competent yeast, along with 200 ng plasmid DNA or 1 µg of integration 
cassette. With every transformation a corresponding control was performed in which a 
similar volume of sterile water was added instead of DNA. Immediately following DNA 
addition, 600 µl of LiAc/PEG buffer was applied and the mixture was incubated for 1 hr at 
30°C under heavy agitation. After incubation, 68 µl of DMSO was added and the 
transformation mixture was placed at 42°C for 15 min under strong aeration. After heat-
shock, the cells were pelleted gently at 1,000 xg and the supernatant removed. The cells 
were resuspended in 60 µl of 1 M sorbitol, plated on the corresponding solid selection 
media and grown for 2 – 3 days at 30°C. Single colonies were transferred to another plate 
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for a second round of selection. Cells were then examined at the protein level for 
conformation of genetic alteration. 
 
2.4.4. Subcellular fraction of yeast, mitochondrial isolation 
 Mitochondria were isolated from yeast through a differential centrifugation 
protocol as previously published (Meisinger et al., 2006). Yeast were cultured in YP media 
containing 3% glycerol overnight to an OD600 reading of 1 – 3. Cell pellets were obtained 
via centrifugation 7,000 xg for 15 min and washed with water. Afterwards, cells were 
resuspended in DTT buffer and kept under mild agitation for 30 min at 30°C. Following 
DTT treatment, cells were recollected, washed with 1.2 M sorbitol and then placed in 
zymolyase buffer (7 ml per g yeast pellet) to which 4 mg of zymolyase was added per g of 
yeast pellet. Zymolyase treatment was performed for 1 hr at 30°C under gentle agitation. 
Spheroplasts were then washed with zymolyase buffer prior to resuspension in pre-cooled 
homogenization buffer. The plasma membrane was opened through 20 strokes of a glass 
Potter S dounce homogenizer set at 800 rpm. Differential centrifugation then commenced 
with the removal of unopened and large cell debris by an initial step at 2,000 xg for 5 min. 
The resulting supernatant was subjected to an additional cleaning step at 7,000 xg for 10 
mins, prior to spinning down the mitochondrial fraction at 17,000 xg for 15 min. The 
mitochondrial fraction pellet was pooled and washed with SEM buffer containing 1 mM 
PMSF. The mitochondrial fraction was analyzed via a Bradford assay enabling the 
normalization of each strain through total protein levels. Protein determination was 
performed with Roti-Quant reagent and a bovine IgG as a standard at concentrations 7.5, 
15, 30 and 60 µg/µl. Three different mitochondrial fraction concentrations were utilized to 
increase protein determination accuracy. After measuring the absorbance at 595 nm, 
mitochondria isolated from various yeast strains were normalized to 10 µg/µl and 
aliquoted prior to flash freezing in liquid N2 and storage at -80°C. 
 
2.5. Purification of recombinant proteins from E. coli 
 
2.5.1. BL21 E coli protein expression 
The BL21 E. coli strain with the protein of interest under the control of the lacZ 
promoter was used for the expression of recombinant proteins. An overnight LB ampicillin 
culture was used to inoculate a fresh LB ampicillin culture to an OD600 value of 0.015, and 
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then placed at 37°C under heavy aeration until an OD600 reading of 0.8 was reached. 1 mM 
IPTG was used for induction and the cells were grown for another 2 – 4 hr (2 hr for 
b2(167)Δ-DHFR and 4 hr for all others). Cells were then collected at 7,000 xg for 15 min 
and frozen at -20°C until needed for purification. 
 
2.5.2. Ion exchange chromatography 
 b2(167)Δ-DHFR was purified through ion exchange chromatography on an ÄKTA 
FPLC system using a Resource S 1 ml column similarly to a previously published protocol 
(Dekker et al., 1997). Frozen cells pellets of expressed b2(167)Δ-DHFR were defrosted and 
resuspended in b2 lysis buffer containing DNase I (1mg per 5 g E. coli wet weight) and 
passed through an EmulsiFlex C5 at 1,000 bar thrice. Lysed cells were pelleted to remove 
all non-soluble entities at 20,000 xg and the supernatant was passed through a 0.2 µM cut-
off syringe filter. Filtered cell lysate was then loaded on a Resource S column using an 
ÄKTA FPLC system set at 0.5 ml/min with b2 buffer A. After loading, the column was 
washed with 10 ml of b2 buffer A at 1 ml/min, allowing for the absorbance at 280 nm of 
the buffer passing over the column to return to a baseline value. After washing, bound 
proteins were eluted at 1 ml/min using b2 buffer B via a linear gradient from 0 – 100% 
buffer B in 10 column volumes. Fractions collected corresponding to the highest 
absorbance values at 280 nm were pooled, aliquoted, flash frozen with liquid N2 and stored 
at -80°C. 
 
2.5.3. Metal affinity chromatography of recombinant proteins 
 E. coli expressed recombinant proteins containing a histidine tag (Tim50IMS, 
Tim21IMS, Tim23IMS, and Tim23YL70AA) were purified using a 1 or 5 ml HisTrap HP 
column, mounted on an ÄTKA FPLC system. Frozen cell pellets were lysed, centrifugally 
clarified and filtered as in section 2.5.2., utilizing either Tim21IMS/Tim23IMS lysis buffer or 
Tim50IMS lysis buffer for the respective proteins. Loading on the HisTrap HP column was 
performed at 0.5 ml/min, after which the column was washed with either 
Tim21IMS/Tim23IMS buffer A or Tim50IMS buffer A as in section 2.5.2. When a stable 
absorbance value at 280 nm was achieved (normally 10 – 20 column volumes of washing 
were required), bound proteins were eluted with a linear gradient of increasing 
corresponding buffer B, containing 500 mM imidazole at a flow rate of 1 ml/min. Peak 280 
nm absorbance fractions were analyzed via SDS-PAGE and Coomassie Brilliant Blue 
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R250 staining (see sections 2.6.1. and 2.6.3. for a detailed descriptions). The cleanest 
fractions were pooled and dialyzed over night in the appropriate buffer, after which the 
protein was concentrated with centrifugal filters. Following concentration, a Bradford 
protein determination assay was preformed using Roti-Quant reagent and BSA as a 
standard at 2, 4, 8, 12 and 16 µg/µl. The absorbance values at 595 nm were read in 
duplicate in a plate reader using a 96 well plate. Following the ascertainment of the 
concentration, small aliquots were made, flash frozen in liquid N2 and stored at -80°C.  
 
2.5.4. Size exclusion chromatography 
 Gel filtration was performed using an ÄKTA FPLC system as a cleaning step 
whenever purity was a problem following HisTrap purification. Depending on the size of 
the recombinant protein and its intrinsic ability to form higher oligomers, either a HiLoad 
16/60 Superdex 200 or 75 was used. Before each run, at least 1.5 column volumes of the 
appropriate buffer were used to equilibrate the column before the protein sample was 
loaded. At a flow rate of 1 ml/min, proteins were separated and fractions were collected, 
which were later examined as in section 2.5.3.  
 
2.6. PAGE protein analysis 
 
2.6.1. SDS-PAGE 
 SDS-PAGE was performed essentially as previously published (Laemmli, 1970) 
using acrylamide (37.5:1 acrylamide:bisacrylamide). A 4% acrylamide gel containing 
0.1% SDS and 1x stacking buffer as a stacking gel, combined with a resolving gel 
containing 10 – 15% acrylamide, 1x resolving buffer and 0.1% SDS was used for SDS-
PAGE. Both sections of the gel were polymerized with 0.1% ammonium peroxodisulphate 
and 0.05% TEMED. Before proteins were applied to the gel, they were mixed with 4x 
protein loading buffer to a final concentration of 1x and placed at 95°C for 5 min. Gels 
were either run in a Mini$PROTEAN®  Cell  (Bio$Rad) or in a custom-made running 
chamber at 20 mA/gel or 30 mA/gel, respectively. 
 
2.6.2. BN-PAGE 
 BN-PAGE was used to resolve native protein complexes and performed essentially 
as previously published (Schägger and Jagow, 1991). Solubilized mitochondria were 
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mixed with 10x BN sample buffer to a final concentration of 1x. Samples were loaded on a 
4 – 13% (for non-radioactive samples) or a 6 – 16.5% gradient gel, cast with a custom-
made gradient mixer, driven by a peristaltic pump. The gel solutions contained the 
appropriate amount of BN acrylamide solution, 1x BN gel buffer and with the higher 
percentage receiving 20% glycerol. After the gradient gel was cast, a 4% stacking gel was 
added, containing 1x BN gel buffer. Gels were run at 600V and 15 mA/gel on a Hoefer 
SE600 Ruby Blue native system at 4°C. For gels which needed to be blotted, the cathode 
buffer was exchanged with cathode buffer without Coomassie Brilliant Blue G250 after the 
sample had entered the resolving section of the gel. 
 
2.6.3. Coomassie Brilliant Blue staining 
 Both polyacrylamide gels as well as PVDF membrane-containing blotted proteins 
were subjected to Coomassie Brilliant Blue staining. Coomassie stainer solution was 
incubated with gels for 60 min and with membranes for 1 min. Following staining 
incubation time, membranes were washed with Coomassie destainer solution for 5 min, 
followed by a 5 min wash in 100% methanol to completely remove the Coomassie before 
commencing with Western-blotting (see section 2.6.5. for details). Gels were washed with 
Coomassie destainer thrice for 30 min to remove non-specific Coomassie staining. 
 
2.6.4. Colloidal Coomassie staining 
 Protein staining of gels intended for mass spectrometric analysis was done through 
colloidal Coomassie staining according to a previously published protocol (Neuhoff et al., 
1988). After electrophoresis, gels were washed with water prior to incubation in colloidal 
Coomassie fixer for 1 hr. Following fixation, gels were washed twice with water and 
placed in colloidal Coomassie stainer overnight or until an acceptable level of staining had 
been achieved. After staining, residual Coomassie was removed with 1% acetic acid and 
then placed in water until needed for mass spectrometric analysis (see section 2.6.7. for 
details). 
 
2.6.5. Western-blotting and immunolabeling of PVDF membrane 
 Following SDS- and BN-PAGE, gels were transferred to PVDF membrane through 
a semi-dry blotting method in PEQLAB chambers. PVDF membrane was activated with 
100% methanol and then placed in blotting buffer. Three layers of Whatman paper, which 
had been previously submerged in blotting buffer was placed on the lower electrode of the 
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chamber. The activated and blotting buffer equilibrated PVDF membrane was placed atop 
of the Whatman paper, followed by the polyacrylamide gel and three additional layers of 
blotting buffer soaked Whatman paper. Before the blotting chamber was closed, all air 
bubbles trapped in between the layers was removed. After sealing the blotting chamber, 
250 mA was applied for 2 hr. 
After the transfer of proteins to the PVDF membrane, the membrane was stained as 
described in section 2.6.3. and then incubated in 5% milk powder dissolved in TBS-T for 1 
hr at room temperature or overnight at 4°C. Following blocking, membranes were shortly 
washed twice with TBS-T prior to incubation in primary antibody for 1 hr at room 
temperature. Membranes were again washed thrice with TBS-T after primary antibody 
incubation for 30 min, after which they were placed in the appropriate secondary antibody 
for 1 hr at room temperature. Immediately prior to signal detection, membranes were 
washed with ample amounts of TBS-T three times for 30 min. Membranes incubated in 
HRP coupled secondary antibody were incubated in enhanced chemiluminescence 
detection reagent and then placed inside of a developing cassette, enabling the exposure 
medical x-ray films to the membranes. Following exposure, films were inserted into an 
Agfa Curix 60 Developing machine. Moreover, membranes were also imaged through the 
use of an LAS 3000 when necessary. Finally, membranes which had been incubated with a 
fluorophore coupled secondary antibody were washed three times for 5 min and then 
placed in a Starion FLA-9000 scanner, where the fluorescently generated signals were 
imaged. 
 
2.6.6. Digital autoradiography 
 Radioactive gels were imaged via digital autoradiography on a Storm 820 
phosphorimager. Polyacrylamide gels were first dried and adhered at a sheet of Whatman 
paper under vacuum at 65°C. Gels were placed under an autoradiography storage phosphor 
screen and exposed for various periods of time before being imaged on a phosphorimager. 
After the image file was generated, key signals were quantified through the use of 
ImageQuant TL v 7.0. 
 
2.6.7. Mass spectrometric analysis of proteins 
 Colloidal Coomassie stained proteins in SDS-PAGE gels were identified and 
analyzed via MALDI nano LC-MS/MS essentially as previously published (Jahn et al., 
2002; Rodríguez-Castañeda et al., 2010; Schulz et al., 2011). First, stained protein bands 
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were excised from the gel and subjected to in-gel tryptic digestion. Gel pieces were 
incubated in a series of solutions: (i) 25 mM NH4HCO3/H2O; (ii) 25 mM NH4HCO3/50% 
acetonitrile; (iii) 100% acetonitrile; (iv) reduction in 10 mM dithiothreitol, 25 mM 
NH4HCO3/H2O at 56°C for 1 hr; (v) steps i – iii repeated; (vi) carbamidomethylation in 25 
mM indoacetamide, 25 mM NH4HCO3/H2O. Digestion was performed with 120 ng of 
trypsin at 37°C overnight. The next morning, peptides were extracted with 1% 
trifluoroacetic acid (TFA), dried in a SpeedVac concentrator, resuspended in 9.5% 
acetonitrile with 0.1% TFA and subjected to reversed-phase chromatography on a 
PepMap100 C18 nano-column (Dionex), mounted on a EASY-nLC (Bruker Daltonics) 
with 9.5% - 90.5% acetonitrile in 0.1% TFA in 80 min. Peptides eluting from the column 
were mixed with matrix solution (4.5% saturated α-cyano-4-hydroxycinnamic acid 
dissolved in 90% acetonitrile, 0.1% TFA and 1 mM NH4H2PO4) and spotted on an 
anchorchip through the use of a Proteineer fc II (Bruker Daltonics). Spotted samples were 
investigated on the chip using an Ultraflextreme (Bruker Daltonics) mass spectrometer 
analyzing MS and post-source decay MS/MS spectra supported with WARP-LC, 
AutoXecute, Flex-Analysis and Biotools software (Bruker Daltonics). Moreover, when 
photo-crosslinking MS/MS based analyses were performed, all software detected potential 
crosslink-containing spectra were reevaluated manually for confirmation. 
 
2.7. In organello mitochondrial assays 
 
2.7.1. In vitro transcription/translation and 35S labeling of proteins 
 35S labeled proteins were obtained through the coupled transcription/translation in a 
rabbit reticulocyte lysate kit. Plasmid DNA, encoding the protein of interest under an SP6 
promoter, was mixed with reticulocyte lysate master mix (1 µg DNA/50 µl reaction 
volume) and [35S]!methionine (100 µC/100 µl), incubated at 30°C for 1.5 hr under mild 
agitation. Following the transcription/translation reaction, the synthesis was quenched with 
50 mM cold methionine, prior to the addition of 300 mM sucrose to provide osmotic 
support in downstream mitochondrial applications. The lysate was analyzed via SDS-
PAGE and digital autoradiography (for details, see sections 2.6.1. and 2.6.6., respectively) 
for the presences of a specific radioactive signal, prior to being flash frozen in liquid N2 
and stored at -80°C until use. 
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2.7.2. In vitro import into isolated mitochondria 
 Both radiolabeled and recombinant proteins were imported into isolated 
mitochondria essentially following the previously published protocol (Wiedemann et al., 
2006). After mitochondria were gently thawed on ice, 75 µg of mitochondrial protein 
fraction were resuspended in 100 µl of import buffer, to which either 1% AVO mix (when 
depletion of the Δψ was required) or ethanol (the corresponding solvent) was added. In the 
case of import times over 20 min, creatine kinase and creatine phosphate were added to the 
import buffer. The import reaction was pre-heated at 25°C for 3 min before the reaction 
was started. Radiolabeled substrates were added at 5 – 10% of the import reaction and 15% 
for non-radiolabeled substrates. After the specified import time, 1% AVO mix was used to 
stop import and the reaction was placed on ice where it was Proteinase K treated (7 µg/100 
µl reaction) for 10 min on ice, with the exception of the Oxa1GIP OM translocation assay, 
which received no Proteinase K. After the digestion of all non-imported substrate, 2 mM 
PMSF was added and the reaction was incubated for 15 min on ice. After, mitochondria 
were pelleted at 20,000 xg for 10 min at 4°C and washed with ample SEM buffer to 
remove BSA from the mitochondrial pellet. Samples to be analyzed via SDS-PAGE were 
resuspended in protein loading buffer supplemented with 2 mM PMSF and incubated at 
95°C for 10 min. Samples intended for BN-PAGE were resuspended in digitonin buffer 
and treated as described in section 2.7.3. 
 
2.7.3. Mitochondrial membrane solubilization 
 Mitochondria were prepared for BN-PAGE through digitonin solubilization closely 
following a previously published procedure (Dekker et al., 1997). The mitochondrial pellet 
obtained via centrifugation at 20,000 xg for 10 min at 4°C was resuspended in digitonin 
buffer through gentle pipetting (20 iterations) and left on ice for 20 min. Following 
membrane solubilization, the lysate was clarified through centrfugation for 10 min at 
20,000 xg, 4°C. After clarification, the supernatent was removed, mixed with 10x BN 
sample buffer to a final concentration of 1x and subjected to BN-PAGE as described in 
section 2.6.2. 
 
2.7.4. In organello crosslinking 
 In organello photo-crosslinking was performed essentially as previously published 
(Schulz et al., 2011). Mitochondria were defrosted gently on ice and added to import buffer 
! 51!
lacking BSA for a final mitochondrial protein concentration of 1 µg/µl. Photo-crosslinking 
reactions in Tom40 mutant mitochondria contained an additional 75 mM NaCl. The 
presequence probe, or the corresponding solvent (10 mM actetic acid), was added to the 
reaction at 2 µM and incubated for 10 min on ice, shielded from ambient light. Following 
the initial incubation on ice, the reactions were subjected to UV irradiation for 30 min on 
ice under a custom-made halogen metal vapor lamp with a glass screen filtering-out 
protein damaging wavelengths below 300 nm. Photo-crosslinking was performed in 1.5 ml 
mirco tubes containing no more than 100 µl to ensure sufficient UV penetration into the 
aqueous reaction. After UV irradiation, mitochondria were pelleted at 20,000 xg at 4°C for 
10 min and washed with SEM buffer prior to the addition of protein loading buffer and 




 Immunoprecipitation was performed with rabbit polyclonal antisera directed 
against Tom22, Tim50 or Tim23 crosslinked to proteinA-sepharose (4 µl serum/µl resin). 
HA immunoprecipitation was performed using mouse monoclonal (12CA5) hybridoma 
supernatant crosslinked to proteinG-sepharose (8 µl supernatant/µl resin). IgG was bound 
to the resin according to the manufacture’s instructions (GE-Healthcare) in 100 mM 
KH2PO4 pH 7.4 and immunoprecipitations were carried-out as previously published 
(Lytovchenko et al., 2013). Following serum or hybridoma supernatant incubation with 
either proteinA- or G-sepharose, DMP crosslinking was performed for 30 min at room 
temperature (6 mg/ml) in 100 mM Na borate/NaOH pH 9.0. Quenching was achieved with 
100 mM Tris/HCl pH 7.4 for either 1 hr at room temperature or overnight at 4°C. 
Quenched, IgG bound resin was washed 3x with ample acetate buffer and the pH was 
neutralized with 100 mM Tris/HCl pH 7.4, prior to storage in 20 mM TBS, 8 mM NaN3 at 
4°C until use. 
 For Tim50, Tim23 and HA immunoprecipitations, mitochondria were resuspended 
in digitonin buffer, lacking digitonin, containing 50 µM pCox4 or Synb2 and incubated on 
ice for 10 min prior to solubilization by the addition in 5% digitonin (as in section 2.7.3.), 
to a final digitonin concentration of 1% and a mitochondrial protein concentration of 2 
µg/µl. For Tom22 immunoprecipitations, mitochondria were resuspended in Tom22 IP 
solubilization buffer at 2 µg/µl, with or without previous subjection to in organello photo-
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crosslinking as explained in section 2.7.4. After solubilization, the clarified supernatant 
was applied to the appropriate resin and subjected to mild agitation for 1 – 2 hr at 4°C. 
Following binding, the unbound fraction was removed and washing with digitonin wash 
buffer was carried out 10 times with ample washing buffer. Bound proteins were eluted 
from the columns with glycine elution buffer twice with three column volumes of buffer at 
room temperature for 5 min under gentle agitation. Bound proteins in HA 
immunoprecipitations were eluted with two column volumes HA peptide (0.5 mg/ml) in 
TBST at 4°C for 10 min under mild agitation. 1 M Tris/HCl pH 8.0 was added to all elutes 
to a final concentration of 500 mM, at which point proteins were precipitated with 20% 
tricarboxylic acid (TCA) and 0.0125% sodium deoxycholate for 15 min on ice. Insoluble 
precipitate was removed via centrifugation at 20,000 xg for 10 min at 4°C. The supernatant 
was removed and the pellet resuspended in protein loading buffer and incubated at 95°C 
for 10 min and analyzed via SDS-PAGE and Western-blotting (see sections 2.6.1. and 
2.6.5., respectively). 
 Following the elution of bound proteins, IgG bound resins were regenerated via 
washing with 10 column volumes of glycine elution buffer for 10 min at room temperature 
under mild agitation. The columns were neutralized with 100 mM Tris/HCl pH 8.0, placed 
in TBS buffer supplemented with 8 mM NaN3 and stored at 4°C for future use.  
 
2.7.6. Metal affinity chromatography of the TOM complex 
 Small-scale isolation of the TOM complex was performed utilizing mitochondria 
isolated from a yeast strain containing a His10 at the C-terminus (Meisinger et al., 2001; 
Model et al., 2008). Mitochondria were solubilized in Tom22His solubilization buffer 
(small scale) at 1 µg/µl for 20 on ice, similar to section 2.7.3. Following incubation, 
clarification of the supernatant was performed via centrifugation at 20,000 xg for 10 min at 
4°C. The supernatant was applied to Ni-NTA agarose (25 µg mitochondrial protein 
fraction/µl resin). The mitochondrial lysate was let incubate with Ni-NTA for 1 – 2 hr 
under gentle agitation at 4°C. Unbound proteins were removed via low speed 
centrifugation (100 xg) and the columns were washed ten times with Tom22His 
solubilization buffer (small scale) containing 0.3% digitonin and 80 mM imidazole. Bound 
proteins were eluted with Tom22His solubilization buffer (small scale) containing 0.3% 
digitonin and 200 mM imidazole. Before photo-crosslinking of the eluate with 2 µM 
photo-peptide, the buffer was exchanged to import buffer with 0.2% digitonin and without 
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BSA through the use of a centrifugal filter. Photo-crosslinking was performed as in section 
2.7.4., however, the washing step following UV irradiation was omitted and the samples 
were analyzed via SDS-PAGE and Western-blotting (see sections 2.6.1. and 2.6.5., 
respectively). 
 Large-scale isolation of the TOM complex was performed, in part, according to the 
previously published procedure (Ahting et al., 1999). Tom22His mitochondria were 
solubilized in Tom22His solubilization buffer (large scale) at 1 µg/ml, and processed 
similarly to the small-scale purification protocol. After binding was performed as in the 
small-scale experiment, the column was washed with Tom22His solubilization buffer (large 
scale) containing 0.5% digitonin and 80 mM imidazole ten times with ample buffer. 
Elution was performed with five column volumes of washing buffer containing 500 mM 
imidazole and elutes were concentrated in a centrifugal filter. Following concentration, the 
buffer was exchanged to import buffer containing 0.5% digitonin without BSA via a PD 
G10 desalting column in accordance with the manufacture’s instructions. Following 
centrifugal clarification of the purified, buffer exchanged TOM complex, photo-
crosslinking was performed identically to the small-scale experiment, and samples were 
analyzed via SDS-PAGE, colloidal Coomassie staining and nano LC-MS/MS (see sections 
2.6.1., 2.6.4. and 2.6.7. for details, respectively). 
 
2.8. In vitro recombinant mitochondrial protein interaction assay 
 Tim21IMS purified from E. coli (see section 2.5.3. for details) and immobilized on 
CNBr-activated sepharose according to the manufacture’s instructions in CNBr Coupling 
buffer overnight at 4°C. Following coupling, the resin was quenched with 100 mM 
Tris/HCl pH 8.0 for 2 hr at room temperature, washed with TBS buffer and then stored in 
TBS with 8 mM NaN3. 20 µl of Tim21IMS bound resin was mixed with 50 nM Tim50IMS, 
and various concentrations of Tim23IMS or Tim23YL70AA in in vitro pull-down binding 
buffer. Following a 1 hr binding incubation at 4°C, the resin was washed with in vitro pull-
down binding buffer ten times and eluted with three column volumes of glycine elution 
buffer. The eluate was then subjected to TCA precipitation as described in section 2.7.5., 
and analyzed via SDS-PAGE and Western-blotting for Tim50 (see sections 2.6.1. and 




2.9. Homology modeling 
 Homology modeling was performed essentially as previously published (Qiu et al., 
2013). The S. cerevisiae Tom40 sequence was submitted to the HHpred server, which 
identified mouse VDAC1 (PDB ID 3EMN) (Ujwal et al., 2008) as the most promising 
homology modeling template as 15% sequence identity was found. The S. cerevisiae 
Tom40 homology model was generated through the use of Modeler (Soding et al., 2005), 
and images presented in this work were generated using Pymol. For aesthetic reasons, 
residues 1 – 48 and 363 – 387 were removed. 
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3.  Results 
 
3.1. Tom40 is a major contributor to TOM presequence interaction. 
 With the aim of investigating presequence-interacting subunits of the TOM 
complex, previously established presequence probes were employed (Schulz et al., 2011). 
These presequence probes, schematically depicted in Fig. 8, were created using the sole 
structural presequence-receptor interaction data available (Abe et al., 2000), consisting of 
an NMR structure of rat Tom20 in complex with the presequence of rat aldehyde 
dehydrogenase (pALDH). Schulz and colleagues placed a UV-activatable crosslinking 
residue, para-benzoylphenylalanine (BPA), at defined locations within the pALDH, 
enabling the investigation of the hydrophobic and hydrophilic interaction surfaces with 
pL19B and pS16B, respectively. Specifically, the BPA residues were positioned to reside on 
either side of the amphipathic α-helix. Furthermore, with downstream mass spectrometry 
based analysis in mind, the authors placed an additional trypsin cleavage site within the 
photo-probes. Finally, both pL19B and pS16B were designed to contain a C-terminal 






















Figure 8. A schematic representation of the presequence probes. Presequence probes were created 
based upon the rat aldehyde dehydrogenase presequence (pALDH). The presequence probes contain 
the UV- activatable crosslinking residue para-benzoylphenylalanine (BPA) at key positions, leucine 
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19 (pL19B) and serine 16 (pS16B). Moreover, the presequence probes were also given an extra trypsin 
cleavage site and both a biotinylated lysine and hexahistidyl tag for detection and purification 
purposes, respectively. 
 
Examining the presequence-interacting subunits of the TOM complex, the 
aforementioned presequence probes were used in conjunction with isolated wild-type 
mitochondria (Fig. 9). Upon separation of the in organello photo-crosslinking reaction via 
SDS-PAGE and detection of TOM subunits via Western-blotting, a photo-adduct could be 
seen with the core subunits of the TOM complex (Tom40 and Tom22), the TOM 
presequence receptors (Tom20 and Tom5) as well as the well established presequence 
receptor, Tim50 (Marom et al., 2011; Schulz et al., 2011) (Fig. 9, lanes 1 – 3). Importantly, 





















Figure 9. In organello photo-crosslinking in isolated wild-type mitochondria, detected via 
Western-blotting and probing for various proteins with specific antisera. PA, photo-adduct. 
Image kindly provided by Dr. Christian Schulz. 
 
 After establishing that TOM complex components form photo-adducts with 
presequence probes, the focus was shifted to Tom40, as a multitude of publications have 
alluded to possible functional interaction of Tom40 with presequence-containing peptides 
in transit across the OM (Baker et al., 1990; Gaikwad and Cumsky, 1994; Gordon et al., 





































al., 1989). With efforts of determining Tom40’s relative contribution of presequence 
interaction within the TOM complex, the translocase was immunoisolated from digitonin-
solubilized isolated wild-type mitochondrial via Tom22 antiserum, having been previously 
subjected to in organello photo-crosslinking. Observed in Fig. 10A, the TOM complex was 
successfully isolated form the mitochondrial lysate as a clear enrichment of TOM subunits 
is seen (lanes 4 – 6, as compared to lanes 1 – 3), while the elates are devoid of other 
membrane integrated proteins of the OM (Por1) and matrix proteins (Aco1). Moreover, as 
seen in lanes 4 – 6, the elution fractions contained photo-adducts of all known direct 
presequence interactors of the TOM complex, as well as Tom40. In order to assess the 
relative presequence probe photo-adduct formation by Tom40, as compared to other 
established TOM presequence receptors, the photo-adducts alone were detected via the 
integrated biotin tag through the use of SA-HRP. When the photo-adducts are detected 
alone in a uniform manner (Fig. 10B), Tom40 exhibits significant presequence probe 
photo-adduct formation, and therefore strongly suggests it plays an active role in the 












































Figure 10. Immunoisolation of the TOM complex via Tom22 antiserum from digitonin-
solubilized wild-type mitochondria, previously subjected to in organello photo-crosslinking. (A) 
Load and eluate (E) samples were resolved via SDS-PAGE and detected via Western-blotting and 
probing for various proteins with specific antisera. Control elution (lane 7) is from resin coupled to a 
nonrelated antibody. Load corresponds to 7% of the eluate. (B) Elution fractions from A were 
detected with SA-HRP. Load from A corresponds to 4% of the eluates in B. PA, photo-adduct. SA-
HRP, Streptavidin horseradish peroxidase. 
 
 Having established Tom40 as a major contributor to presequence interaction at the 
TOM complex, the effect on the deletion of known presequence-binding subunits or 
domains flanking the Tom40 channel was assessed via presequence probe photo-
crosslinking. This analysis allowed for the investigation of the possible indirect Tom40 
photo-adduct formation, as BPA has previously demonstrated a very dynamic active radius 
(3 – 15 Å) (Dormán and Prestwich, 1994; Schulz et al., 2011; Wittelsberger et al., 2006). 
As seen in Fig. 11, the Tom40 photo-adduct in mitochondria lacking Tom5 or the IMS 
domain of Tom22 was effectively unaltered, similarly to the established OM and IM 






















Figure 11. In organello photo-crosslinking in mutant and corresponding wild-type 
mitochondria. Samples were resolved via SDS-PAGE and detected via Western-blotting and probing 
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 The data set described above presents Tom40 as an independent presequence 
interactor of the TOM complex, which plays a significant presequence-binding role at the 
TOM complex. 
 
3.2. Tom40 displays two discrete presequence-interacting regions. 
 During the creation of the presequence probes, the BPA residue was chosen 
specifically due to its very stable nature and, most importantly, upon UV irradiation stable 
C-C bonds are created (Dormán and Prestwich, 1994). As the result of the UV induced 
stable C-C covalent bond formation of the BPA photo-crosslink, downstream mass 
spectrometric pinpointing of the crosslink site was made possible. Therefore, the 
presequence-interacting regions of Tom40 were mapped through a combine photo-
crosslinking/mass spectrometry approach (Fig. 12). A prerequisite to mass spectrometry 
based ascertainment of the photo-crosslinking sites is the clean isolation of receptors 
yielding a significant subset of photo-crosslinked species in Coomassie stainable amounts. 
Therefore, a TOM isolation approach employing mitochondria containing a decahistidyl 
tag at the C-terminus of Tom22, in which the TOM complex was first isolated from 
digitonin-solubilized mitochondria and then subjected to photo-crosslinking was adopted, 


















Figure 12. Workflow of joint photo-crosslinking/mass spectrometry approach to Tom40 





Solubilization in digitonin 
and Ni-NTA purification 




 Before preparative-scale TOM complex isolations were performed, small-scale 
photo-crosslinking was carried out with the Tom22HIS Ni-NTA elutes. Observed in Fig. 13, 
the TOM complex is cleanly isolated from a Tom22HIS mitochondrial lysate and TOM 
receptor photo-adducts are formed similarly to what was seen in in organello experiments. 























Figure 13. Ni-NTA isolation of the TOM complex from digitonin-solubilized Tom22HIS 
mitochondria, followed by in vitro TOM complex photo-crosslinking. Samples were resolved via 
SDS-PAGE and detected via Western-blotting and probed for various proteins with specific antisera. 
PA, photo-adduct. Load 5% of eluate (E). Image kindly provided by Dr. Christian Schulz. 
 
 Following the conformation of the small-scale test as seen in Fig. 13, preparative-
scale TOM complex isolations were performed, followed by photo-crosslinking as outlined 
in Fig. 12. As initial Ni-NTA mediated TOM isolation experiments only showed 
significant colloidal Coomassie staining for Tom40 (data not shown), an SDS-PAGE gel 
system optimized for the separation of Tom40 from its photo-adducts was chosen. 
Preparative-scale in vitro photo-crosslinking of Ni-NTA isolated yeast TOM complex led 































to the efficient ascertainment of colloidal Coomassie stainable photo-crosslinked Tom40 
species (Fig. 14). It should be noted that approximately the same Tom40 photo-


















Figure 14. Preparative-scale Ni-NTA isolation of the TOM complex from digitonin-solubilized 
Tom22HIS mitochondria, followed by in vitro TOM complex photo-crosslinking. Samples were 
resolved via SDS-PAGE and detected via colloidal Coomassie staining. PA, photo-adduct. 
 
 Colloidal Coomassie stained bands corresponding to Tom40 presequence probe 
photo-adducts were analyzed via MALDI nano LC-MS/MS. MS/MS spectra of tryptic 
fragments corresponding to photo-crosslink containing precursor masses are shown in Fig. 
15, with A – C corresponding to pL19B crosslinks and D and E corresponding to pS16B 
crosslinks. The identification of a single crosslinked residue was, in one case, successful, 
with M94 of Tom40 identified to have been crosslinked to the BPA residue of pL19B. This 
identification was made possible due to the characteristic fragmentation pattern of the Met 
side chain when containing a BPA crosslink (Rodríguez-Castañeda et al., 2010; Schulz et 
al., 2011). However, other Tom40 tryptic fragments crosslinked to presequence probes 
could only be narrowed down to the dipeptide 182TL183 (Fig. 15E) and the heptapeptide 
228AGVSYLT234 (Fig. 15A and D) due to the unforeseen instability of newly formed C-C 
bonds between BPA and Tom40 under the mass spectrometric sequencing conditions. 
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Figure 15. Fragment ion mass spectra of presequence-probe crosslinked Tom40 peptides. The b- 
and y-ions are indicated by b+ and y+ when carrying a crosslink to tryptic fragments of pL19B (A – C) 
or pS16B (D and E). Fragment ions resulting from cleavage of the crosslink bond are labeled with the 
respective tryptic peptide sequence. (A) Tom40220-235 crosslinked to pL19B18-24; [M+H]+obs = 2405.17, 
[M+H]+calc = 2405.17; internal fragments with N-terminal Pro are indicated; the y8+-ion identifies 
228AGVSYLT234 as the minimal crosslinking site. (B) Tom4091-113 crosslinked to pL19B18-24; [M+H]+obs 
= 3305.66, [M+H]+calc = 3305.64. The b5+-ion together with the indicative triplet signal (marked by 
asterisks) identified M94 as the crosslinking site. (C) Tom40182-190 crosslinked to pL19B18-24; [M+H]+obs 
= 1860.94, [M+H]+calc = 1860.95. (D) Tom40220-235 crosslinked to pS16B15-17; [M+H]+obs = 2105.02, 
[M+H]+calc = 2105.03; the y8+-ion identifies 228AGVSYLT234 as the minimal crosslinking site. (E) 
Tom40182-190 crosslinked to pS16B15-17; [M+H]+obs = 1560.80, [M+H]+calc = 1560.81; the b+ ion series 
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of another nearly isobaric Tom40 peptide co-isolated in the precursor selection window. 
Measurements performed in close cooperation with Drs. Bernhardt Schmidt and Olaf Jahn. 
 
 Fortunately, the recent presentation of both a limited proteolysis and site-specific 
crosslinking verified Tom40 homology model allowed for the placement of mass 
spectrometry derived presequence-interacting regions (Gessmann et al., 2011; Qiu et al., 
2013). When the three identified presequence interaction regions are placed within the 
homology structure (Fig. 16 A – C), two spatially distinct presequence active sites are 
seen, the first uncovered through the crosslink to M94 (Fig. 16, III) and the second 








































Figure 16. Tom40 homology model based upon the mouse VDAC structure (PDB ID 3EMN). 
Photo-crosslinked residues or fragments in orange and T220 in red. I, 228AGVSYLT234. II, 182TL183. 
III, M94. (A) lateral view, (B) top view and (C) lateral cutout view. 
 
 Fortuitously, one of the two presequence-interacting sites of Tom40 was outlined to 
a higher resolution (Fig. 16, I and II), allowing for the more targeted analysis of key 
resides in the pocket, with the aim of presequence-specific Tom40 mutant construction. 
 
3.3. TOM complex stability is unaltered in Tom40 phosphomimetic (T220E) and 
phosphoblock (T220V) mutants. 
Examining a recent publication on the phospho-status of the TOM complex 
(Schmidt et al., 2011), the phosphorylation of Tom40 was seen to take place within the 
center of the identified presequence-interacting region by a presently elusive kinase. This 
residue, T220 (Fig. 16, highlighted in red), was then utilized in the conformation of the 
presequence-interacting region as well as the functional characterization of the binding 
site, through the creation of the phospho-mimetic mutant T220E and the phospho-block 
mutant T220V. Importantly, this allowed for physiologically grounded Tom40 mutant 
construction, thereby avoiding compounding effects from the well-known assembly and 
stability pitfalls of mutating Tom40 (Gabriel et al., 2003; Sherman et al., 2006). 
 Creation of the Tom40 mutants was accomplished through the transformation of a 
tom40∆ yeast strain carrying a plasmid encoding TOM40 along with a URA3 selection 
marker (Kutik et al., 2008; Qiu et al., 2013). This strain was transformed with a pFL39 
plasmid encoding tom40E mut or tom40V mut, as well as the TRP1 selection marker. 
Following transformation, yeast were grown on synthetic solid media lacking both uracil 
and tryptophan, allowing for the retention of both TOM40 allele containing plasmids. 
Colonies were then subjected to 5-FOA mediated plasmid loss, triggering the growth of 
only cells which have lost the wild-type TOM40 allele containing plasmid as it also 
contained the URA3 selection marker. As seen in Fig. 17A, 5-FOA induced plasmid loss 
clearly indicates the viability of the newly created TOM40 alleles, as cells demonstrated 
wild-type-like colony formation. Moreover, the negative control strain, lacking a non-
URA3 containing TOM40 allele plasmid, was, as expected, unable to form colonies on the 
5-FOA containing media. Furthermore, an in-depth yeast dilution growth analysis (Fig. 
! 66!
17B) illustrated completely unaltered growth on non-fermentable media across a wide 











Figure 17. tom40E mut and tom40V mut alleles display no growth phenotype and wild-type-like 
TOM stability. (A) Yeast containing a chromosomal deletion of TOM40, complemented by wild-type 
TOM40 within a URA3 selection plasmid, were transformed with plasmids containing TOM40 alleles 
as indicated and subjected to plasmid loss on 5-FOA containing medium. (B) Serial dilutions (10-
fold) of the indicated strains were incubated at the indicated temperature for three days on non-
fermentable medium. 
 
 Mitochondria were isolated from the yeast strains containing the phospho-mutant 
TOM40 alleles and selected mitochondrial proteins were examined through SDS-PAGE 
and Western-blotting utilizing specific antisera (Fig. 18A). As hinted upon by the dilution 
based growth test in Fig. 12B, no differences in mitochondrial protein levels were detected 
upon comparison of the mutant Tom40 containing mitochondrial (Fig. 18A, lanes 4 – 9), as 
compared with the corresponding wild-type (Fig. 18A, lanes 1 – 3). Importantly, the 
Tom40 levels as well as the rest of the TOM complex subunits examined were seen to 
display unaltered protein amounts both among the mutants and compared to the wild-type.  
 The stability of the TOM complex was monitored through BN-PAGE separation of 
digitonin-solubilized mitochondria. As shown in Fig. 18B, TOM complex migration, when 
detected via Tom40, was unaltered across the phospho-mutants as specific signal was 


























Tom40 mutant containing mitochondria, detected via Rip1 and Atp5 respectively, showed 
unchanged migration on BN-PAGE. Taken together, the aforementioned protein level and 
stability assays demonstrate unaltered TOM characteristics and support the subsequent 
functional analysis of the Tom40 phospho-mutants, as non-specific protein level and 
stability issues are not present. 
 
Figure 18. Tom40 phospho-mutants exhibit wild-type-like mitochondrial protein levels and 
TOM stability. (A) Western blot analysis of steady-state protein levels in indicated strains from 
isolated mitochondria via SDS-PAGE using specified antisera. (B) BN-PAGE Western blot analysis 
of steady-state complex levels using antisera for Tom40, Atp5 and Rip1 using 40 µg, 15 µg and 15 µg 
isolated mitochondrial protein respectively. 
 
3.4. Import analysis of Tom40 phospho-mutants. 
 Following the TOM protein steady-state levels and stability analysis, conformation 
of the presequence specificity of the mutants was carried out, through the use of photo-
crosslinking with the pL19B (Fig. 19). In this in organello photo-crosslinking experiment, 
pL19B was chosen as it was designed to monitor the hydrophobic presequence receptor 
interface, therefore its photo-adducts are expected to exhibit resilience in the higher salt 
conditions implemented in the experiment. As a specific Tom40 photo-adduct reduction 
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presequence-binding significance of the newly mapped Tom40 binding site could be 
confirmed. Importantly, presequence probe photo-adduct formation with established IM 
presequence translocase receptors Tim23 and Tim50 was not reduced in Tom40E 
mitochondria. It should be noted that the reduction in Tom40 photo-adduct formation in 
Tom40E mitochondria couldn’t be simply due to the unspecific introduction of a negatively 
charged residue in a key area. The presequence exhibits a net positive charge which, if 
only electrostatic interaction were at play, should increase the presequence-binding 
affinity, yet a decrease in Tom40’s photo-adduct was seen in this strain. This notion also 
strongly suggests that a more complicated presequence-binding regulatory mechanism is at 
play within Tom40. This key finding allows for both the validation of the joint 
presequence probe photo-crosslinking/mass spectrometry approach, as well as 
demonstrating Tom40’s direct role in presequence-binding. 
 
Figure 19. Photo-crosslinking in isolated Tom40E and Tom40V mitochondria. (A) In organello 
photo-crosslinking analysis in isolated Tom40E and Tom40V mitochondria, imaged via Western-
blotting utilizing the indicated antisera. PA, photo-adduct. 
 
 After conformation of presequence-binding augmentation within the Tom40 
phospho-mutants, functional import analyses were performed, with the non-presequence 
related carrier and MIA pathways monitored. The carrier pathway was assessed through 
the import and assembly of [35S]AAC, followed by the native separation of digitonin-
treated mitochondria lysate and digital autoradiography (Fig. 20A). Tom40 mutant 
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mitochondria displayed an unaltered ability in the assembly of the carrier pathway 
substrate. Moreover, [35S]Tim9, a MIA pathway substrate, was urea denatured and 
imported into Tom40 mutant mitochondria, separated via reducing SDS-PAGE and 
analyzed via digital autoradiography (Fig. 20B). When evaluating the MIA pathway import 
capacity of the Tom40 phospho-mutants, no striking difference was found. It should be 
mentioned that a slight reduction in Tom40V-containing mitochondria was observed, yet 
the reduction was within the range of error of the corresponding wild-type. 
 
Figure 20. Carrier and MIA pathway import analyses in Tom40 phospho-mutant mitochondria. 
(A) [35S]AAC was imported and assembled into isolated mitochondria from the indicated strains, 
followed by digitonin solubilization and BN-PAGE. The fully assembled AAC dimer was quantified 
via digital autoradiography and presented as % of wild-type (n = 4, SEM). (B) Urea denatured 
[35S]Tim9 was imported into isolated mitochondria and resolved via reducing SDS-PAGE. Proteinase 
K protected imported Tim9 was quantified and presented as % wild-type (n = 3, SEM). Tim9 import 
experiments were performed by Dr. Lidia Wrobel (Warsaw, Poland). 
 
 
3.5. Functional characterization of TOM translocation intermediates within 
Tom40 phospho-mutants. 
 Following the establishment of TOM functionality through the import of both 
carrier and MIA pathway substrates, the translocation of a presequence-containing 
precursor was monitored during TOM passage. In this assay, Oxa1, a presequence-
containing substrate targeted to the mitochondrial matrix via TOM and TIM23, was 






























membrane potential was depleted through the addition of an inhibitor cocktail (AVO – 
antimycin A, valinomycin and oligomycin) prior to commencing the import reaction. 
Under these conditions the Oxa1 substrate is known to produce a stable and productive 
TOM complex intermediate (Frazier et al., 2003). Therefore, [35S]Oxa1 was imported into 
Tom40 phospho-mutant mitochondria with and without Δψ, solubilized in digitonin buffer, 
resolved via BN-PAGE and imaged through digital autoradiography (Fig. 21). Evaluating 
the Oxa1 TOM (known within this assay as the general import pore [GIP]) intermediate 
within the Tom40 phospho-mutants, a striking alteration in presequence mediated TOM 
translocation kinetics is seen. The Tom40V-containing mitochondria show an unexpected 
increase in TOM translocation kinetics when compared to both the wild-type and the 
Tom40E-containing mitochondria, resulting in a 43% increase in presequence translocation 
capacity at the 30 min time point. This finding thus allows for the Tom40-presequence-
probe mapped binding site investigated in this study to be functionally connected to 
presequence mediated import across the mitochondrial OM. 
 
Figure 21. Presequence mediated TOM translocation analysis in Tom40 phospho-mutant 
mitochondria. (A) [35S]Oxa1 was imported with and without Δψ and analyzed via BN-PAGE and digital 
autoradiography. An Oxa1GIP intermediate autoradiograph is presented with the quantification presented 
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3.6. Investigating the functional relationship between the presequence-binding 
sites of Tom40 and Tom22IMS. 
 Having established that a functional presequence-binding site within the Tom40 
channel exists, the question was raised as to its relationship with the nearby and well 
established presequence-binding site of Tom22IMS (Frazier et al., 2003; Komiya et al., 
1998; Moczko et al., 1997; Shiota et al., 2011). In order to address this issue, a series of 
double mutant yeast strains were created, corresponding to the previously established 
Tom40 T220 phospho-mutants, in conjunction with the established deletion of the Tom22 
IMS domain via the tom22-2 allele (Moczko et al., 1997). Specifically, competent tom40∆ 
yeast containing either TOM40, tom40E mut or tom40V mut on a plasmid were transformed 
with a PCR-generated integration cassette, enabling the chromosomal deletion of the 
Tom22 IMS domain as previously published (Frazier et al., 2003; Moczko et al., 1997). 
These newly generated double mutant yeast strains were applied to non-fermentable solid 
media in a dilution growth test over a range of temperatures (Fig. 22A). As seen in the 
image below, the addition of the Tom22 IMS domain deletion had no effect on the growth 
of the Tom40 phospho-mutant strains.  
Mitochondria were isolated from the newly created yeast strains and steady-state 
protein levels of selected mitochondrial-resident proteins were assessed via SDS-PAGE 
and Western-blotting (Fig. 22B). Careful analysis of the Western blot images revealed 
unaltered protein levels in the double mutant strains, and particularly, examined TOM 
complex constituents displayed equal protein amounts across all strains. As TOM subunits 
in all double mutant strains exhibited wild-type-like steady-state protein levels, the 
stability of the double mutant TOM complexes was assessed via digitonin solubilization, 
BN-PAGE and Western-blotting (Fig. 22C). Similarly to what was seen in the single 
Tom40 phospho-mutants (Fig. 18B), the examined TOM complexes as well as complexes 
III and IV of the respiratory chain from the double mutant strains were shown to migrate 
equally on BN-PAGE. However, in strains containing Tom22-2, the TOM complex was 
seen to travel slightly faster as compared to the wild-type TOM complex (Tom22-2 
containing TOM ~ 300 kDa, wild-type TOM ~ 400 kDa), due to the deletion of the Tom22 
IMS domain. The difference in TOM BN-PAGE migration due to the deletion of the IMS 
domain of Tom22 is likely related to alteration in TOM containing digitonin micelles, as 
the IMS domain is less than 4 kDa in size. 
! 72!
Succinctly, the aforementioned growth, protein steady-state and TOM stability 
analyses demonstrate wild-type-like TOM characteristics, and allow for further functional 
presequence-specific import analysis to proceed without the hindrance of indirect effects.  
 
Figure 22. tom40E mut and tom40V mut alleles display unaffected growth, protein levels and TOM 
stability in the tom22-2 background. (A) Serial dilutions (10-fold) of the tested strains were 
incubated at the indicated temperature for three days on non-fermentable medium. (B) Western blot 
analysis of steady-state protein levels in isolated mitochondria from the indicated strains via SDS-
PAGE, using specified antisera. (C) BN-PAGE Western blot analysis of steady-state complex levels 
using antisera for Tom40, Atp5 and Rip1 using 40 µg, 15 µg and 15 µg isolated mitochondrial 
protein, respectively. 
 
 In order to investigate presequence mediated translocation over the TOM complex 
in the Tom40 phospho-mutants within the tom22-2 background, the Oxa1-TOM 
translocation intermediate assay was utilized, as previously performed in the Tom40 single 
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containing mitochondria within the wild-type background (Fig. 21), the deletion of the 
Tom22 IMS domain resulted in an approximately 25% drop in the Oxa1-TOM 
translocation intermediate, specifically in the Tom40 phospho-mutants. 
 
Figure 23. tom40E mut and tom40V mut alleles equally exhibit reduced TOM presequence 
translocation in the tom22-2 background. [35S]Oxa1 was imported with and without Δψ as 
indicated into mitochondria isolated from the inferred strains and analyzed by BN-PAGE. An 
autoradiograph of the Oxa1GIP intermediate is displayed and quantification was preformed and 
presented as % of wild-type at 30 min. Image provided by Dr. Christian Schulz. 
 
 In summary, the analysis of Tom40 phospho-mutants in the tom22-2 background, 
compared to the results of the functional analysis in the single Tom40 phospho-mutants, 
allowed for a defined set of conclusions to be drawn. First of which, Tom40 possesses a 
posttranslationally regulated presequence-binding site functionally involved in 
presequence mediated mitochondrial OM translocation. This evidence is seen in the 
specific reduction of presequence probe photo-adduct formation in mitochondria 
containing Tom40E, and conversely, presequence mediated import over the TOM complex 
is kinetically accelerated in Tom40V mitochondria while exhibiting wild-type-like 
presequence probe photo-adduct formation. Nonetheless, both Tom40 phospho-mutants 
are uniquely sensitive to the deletion of the Tom22 IMS domain, allowing for the 
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mitochondria to the activities of the lone established trans-acting TOM presequence-
binding domain, Tom22IMS. Attempting to better understand the possibly conflicting 
Tom40 phospho-mutant presequence interaction data, a detailed import analysis was 
performed at saturating conditions, pushing the translocation capacity of the TOM 
complex to maximal activity. 
 
3.7. Tom40 phosphorylation at T220 allows for the manipulation of import kinetics 
along the presequence pathway. 
 Employing the use of the well characterized, artificial mitochondrial substrate 
b2(167)∆-DHFR, comprised of the first 167 residues from cytochrome b2 (lacking the 
endogenous stop-transfer signal, hence the ∆), combined with mouse DHFR, presequence 
mediated matrix-targeted import was examined in Tom40 phoshpo-mutants. The artificial 
substrate was expressed recombinant and purified via ion-exchange chromatography 
through a previously published protocol, allowing for the retention of import competency 
(Dekker et al., 1997). The use of a recombinant substrate, as opposed to previous import 
assays utilizing an [35S]Met reticulocyte lysate system, enabled the assessment of import 
under translocase saturating conditions. 
 As seen in Fig. 24A and B, b2(167)∆-DHFR was imported and processed by the 
matrix resident MPP (seen in Fig. 19A as i) and a presently elusive peptidase (seen in Fig. 
24A as i*) in the Tom40 phospho-mutants in a manner which enabled the kinetic 
resolution of presequence mediated matrix import. Examining the quantification of 
presequence import across the Tom40 phospho-mutant containing mitochondria, 
employing a fluorescence based Western blot detection method, opposing import kinetics 
was revealed. Tom40V-containing mitochondria displayed wild-type-like import kinetics 
during the initial linear import phase, however, these mitochondria appear to have 
remained in the linear phase for an extended period of time, resulting in an ~ 25% increase 
in overall import capacity in the saturation phase of the import curve. Conversely, 
Tom40E-containing mitochondria exhibited an overall drop in presequence import, seen 
more prevalently in the early time points as the Tom40E mutant mitochondria were able to 
approach wild-type levels at saturation. Taken together, the matrix-targeted presequence 
import phenotypes exhibited by the Tom40 phospho-mutants are supported by the 
aforementioned data, specifically, the reduction in Tom40E presequence-binding as 
assessed by photo-crosslinking with the presequence probes. In the case of Tom40V, the 
increase in TOM translocation kinetics, as monitored by the Oxa1-TOM translocation 
! 75!





Figure 24. Tom40E and Tom40V mitochondria exhibit opposing alterations in presequence 
mediated matrix import kinetics. (A) Purified b2(167)∆-DHFR was imported into isolated 
mitochondria from the indicated strains, proteinase K treated and analyzed via Western-blotting and 
fluorescence-based digital imaging using anti-DHFR antiserum. Precursor lane represents 15% of the 
input. (B) Quantification of import reactions described in A. The processed intermediates are shown 
as % of wild-type at 20 min (n = 3, SEM). p, precursor. i and i*, processed intermediates. 
 
 Attempting to better understand the functional relationship between the presently 
characterized Tom40 presequence-binding site and the single established late acting TOM 
presequence-binding site Tom22IMS, mitochondria from the previously created Tom40 
phospho-mutants in the tom22-2 background were used in the saturating b2(167)∆-DHFR 
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both of the Tom40 T220 phospho-mutant strains, when compared to the corresponding 
wild-type. Careful examination of the import kinetics revealed that the Tom40V mutant, as 
compared to the Tom40E mutant and particularly the wild-type, suffered particularly from 
the loss of the Tom22IMS domain, allowing for the gain of import capacity seen in Fig. 24 
to be functionally linked to the TOM trans-acting presequence-binding site. This result 
parallels the findings from the Oxa1-TOM intermediate assay (Fig. 21 compared to Fig. 
23), which also found the IMS domain of Tom22 to mediate the increase in TOM 













Figure 25. Tom40E and Tom40V mitochondria display sensitivity to the loss of Tom22IMS in 
presequence mediated matrix import. Purified b2(167)∆-DHFR was imported into mitochondria 
isolated from Tom40 phospho-mutant strains in the tom22-2 background, proteinase K treated and 
analyzed via Western-blotting, employing anti-DHFR antiserum. Precursor lane represents 15% of the 
input. p, precursor. i, processed intermediate. 
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3.8. The characterization of a novel TIM23 interaction between Tim50 and Tim21. 
 As presequence-containing precursors exit the OM TOM channel, they 
immediately come into contact with receptors of the presequence translocase while still 
stably associated with TOM (Albrecht et al., 2006; Chacinska et al., 2005; Mokranjac et 
al., 2005; Popov-Celeketić et al., 2008a). Specifically, both Tim21 and Tim50 have been 
observed to interact with either IMS residing TOM subunits or the presequence-containing 
substrate in complex with TOM. Moreover, these interactions are known to exhibit 
functional independence of the Δψ, signifying the early actions of these IM bound 
presequence translocase receptors, proceeding presequence-induced TIM23 channel 
opening (Meinecke et al., 2006; Truscott et al., 2001).  
The various sorting routes employed by the multi-faced presequence translocase 
demand its demonstrated highly dynamic nature (Chacinska et al., 2009; Dudek et al., 
2013; van der Laan et al., 2010). These dynamic events have been observed throughout 
literature as a plethora of intra-translocase interactions (see section 1.3.1. for a detailed 
description), and are now known to be functionally linked to the active import of the 
heterogeneous class of presequence-containing substrates. Investigating key Tim50 
interaction partners through its single cysteine residue, a chemical crosslinking approach 
was employed by applying a highly spatially restrictive cysteine active crosslinker 
(exhibits and active radius of ∼ 3 Å), namely Cu2+ (Lytovchenko et al., 2013). In this 
study, Tim21 (also containing a single endogenous cysteine residue, C128) was 
unequivocally identified to form a Cu2+-induced intermolecular disulfide-bond with Tim50 
(published findings summarized in Fig. 26). Moreover, the findings by Lytovchenko et al. 
demonstrated the sensitivity of the Tim50-Tim21 interaction to presequence addition, as 
the specific crosslinking adduct band disappeared with the preincubation of mitochondria 











Figure 26. Tim21 can be crosslinked to Tim50 in a presequence sensitive manner. (A) Cu2+ 
crosslinking in isolated mitochondria stabilizes the association of Tim50 to Tim21. (B) Following the 
addition of presequence peptide, the Tim50-Tim21 complex dissociates. Model summarizes 
previously published findings (Lytovchenko et al., 2013). 
 
! As Lytovchenko and colleagues had established the Tim50-Tim21 interaction in 
organello, the association was further investigated upon via examination within a defined 
in vitro system. The use of this unambiguous experimental set-up allowed for the 
investigation of the potential roles other TIM23 constituents instilled on the newly 
described Tim50-Tim21 interaction, specifically the impact of the Tim23IMS domain. 
Tim23 represented a key TIM23 component to be investigated in the in vitro system as it 
represents the only other presequence translocase subunit containing a functionally 
relevant IMS domain. Moreover, critical residues within Tim23IMS responsible for its 
presequence import-conferring Tim50 interaction have been identified (Gevorkyan-
Airapetov et al., 2009), namely 70YL71. In order to achieve this, the IMS domains of Tim23 
(both wild-type and YL70AA mutant), Tim50 and Tim21 were recombinantly expressed 
and purified. 
Tim21IMS was immobilized on resin and Tim50IMS was added to the system at a 
steady concentration, while the amount of the third component, Tim23IMS was titrated in. 
Bound Tim50IMS was eluted and visualized via SDS-PAGE and Western-blotting (Fig. 27). 
























Tim23IMS (seen in Fig. 27A, lane 2 compared to lane 6), however, the addition of Tim50 
binding competent Tim23IMS to the in vitro system was shown to increase Tim50IMS’s 
association with Tim21IMS by over twofold (Fig. 27B). Moreover, as previously established 
by Gevorkyan-Airapetov and colleagues, the Tim50 binding incompetent mutant Tim23IMS 
construct (Gevorkyan-Airapetov et al., 2009) Tim23YL70AA was unable to initiate increased 
recovery of Tim50IMS from the Tim21IMS resin in the in vitro system. This finding signifies 
the requirement of Tim23’s interaction with Tim50, in the construction of the Tim21-
Tim50 interaction. Finally, this notion is suggestive of tertiary complex formation with 
Tim23 acting as a bridge between Tim50 and Tim21, however, the possibility of an 




Figure 27. Tim23IMS establishes the Tim21-Tim50 interaction. (A) Tim21IMS was bound to CNBr-
activated Sepharose and mixed with 20 nM Tim50IMS in the presence of the indicated concentrations 
of Tim23IMS WT or Tim23IMS YL70AA. Protein bound on the Tim21IMS resin was acidically eluted and 
analyzed by SDS-PAGE and Western-blotting using Tim50 antiserum. (B) Quantification of 
Tim50IMS signal intensities, as in (A), presented as mean ± SEM, N = 3. 
 
3.9. Presequences trigger the dissociation of Tim50 from Tim21 and prime the 
presequence translocase for translocation. 
 As the previous assay indisputably established the interaction between Tim21, 
Tim23 and Tim50, the significance of this association in mitochondria was questioned. 
Specifically, what role the signal sequences had on the newly described interaction within 
the context of a primed vs. default state translocase within a mitochondrial setting. In order 
to investigate this concept, a presequence translocase priming assay was combined with 
immunoisolation of the TIM23 complex via Tim23 as well as Tim50. In detail, co-
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immunoprecipitation experiments were performed with Tim50 and Tim23 antisera 
utilizing digitonin-solubilized mitochondria that had previously been primed through the 
incubation in pCox4, or left in the default state via addition of Synb2 (similar in 
composition to pCox4, but fails to target substrates to mitochondria [Allison and Schatz, 
1986]) or buffer incubation (Fig. 28). Importantly, this assay allowed for the detection of 
dynamic TIM23 subunits as the experimental set-up enables the discrimination between 
the primed and default state translocase. Investigation of the co-immunoprecipitation 
results importantly observed the highly significant (Fig. 28B, left panel) dissociation of 
Tim21 from Tim50 upon pCox4 addition as compared to the controls (Fig. 28A, lane 5 
compared to lanes 4 and 6). This observation was validated by the fact that Tim50 and 
Tim23 were isolated in equal efficiencies across all mitochondrial pre-treatment conditions 
when the respective antiserum was used. Moreover, the dissociation of Tim21 from Tim50 
was shown to occur at the presequence translocase and not in a free Tim21-Tim50 pool as 
the same statistically significant dissociation was observed when Tim23 antiserum was 
used. Of particular interest, Pam17, the established early TIM23 integrating PAM subunit 
presumed to be responsible for the subsequent association of the Pam16/Pam18 complex 
(Popov-Celeketić et al., 2008a; Schiller, 2009; van der Laan et al., 2005), was shown to 
exhibit reciprocal behavior when compared to Tim21 in both Tim50 and Tim23 co-
immunoprecipitation experiments (Fig. 28). Taken together, these findings effectively 
linked presequence presentation in the IMS with the dissociation of the Tim23 mediated 
Tim21-Tim50 interaction at the presequence translocase resulting in the subsequent 
































Figure 28. Tim50 and Tim21 dissociate upon signal sequence binding at the presequence 
translocase, leading to Pam17 association. (A) Co-immunoprecipitation was carried out with Tim50 
or Tim23 antisera using digitonin-solubilized mitochondria preceded by the pre-treatment with 
pCox4, SynB2, or buffer. Control immunoprecipitation used a translocase distant antiserum. Bound 
proteins were acidically eluted and analyzed by SDS-PAGE and Western-blotting. Total represents 
7% of the elution. (B) Seven independent co-immunoprecipitation experiments employing pCox4 and 
SynB2 pre-treatment using Tim50 (left panel) or Tim23 (right panel) antisera as performed in (A) 
were quantified and normalized to precipitated Tim50 or Tim23, with the SynB2 peptide control set at 
100%. Data are presented as mean ± SEM, N = 7. Statistical significance was evaluated using a two-
sided t-test. *, P < 0.05; **, P < 0.01; ***, P < 0.0001. 
 
 Further investigation into the presequence-triggered dissociation of Tim21 from 
Tim50 at the TIM23 complex questioned the significance of the established C-terminal 
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mitochondria were isolated from a strain in which TIM50 was placed under the control of 
the GAL1 promoter and carrying either a plasmid encoding Tim50HA or Tim501-361-HA. 
Before yeast were subjected to mitochondrial isolation the galactose was removed from the 
culture media, enabling the depletion of the genomically encoded Tim50, thereby allowing 























Figure 29. Tim50’s presequence-binding domain is dispensable in the presequence-triggered 
dissociation of Tim21 from Tim50. Co-immunoprecipitation was carried out using anti-HA mouse 
monoclonal antibody and digitonin-solubilized mitochondria containing Tim50HA and Tim501-361-HA, 
pre-treated with pCox4, Synb2 or buffer. Bound proteins were acidically eluted and analyzed by SDS-
PAGE and Western-blotting. Total represents 7% of the elution. Anti-Myc mouse monoclonal 
antibody (9E10) was used as an immunoprecipitation specificity control. 
 
 As seen in Fig. 29, HA resin successfully isolated both Tim50 variants to equal 
degrees across all mitochondrial pre-treatment conditions as similar amounts of Tim50HA 
or Tim501-361-HA were recovered. Moreover, as demonstrated by the unvaried levels of 
Tim23 co-immunoprecipitation, both Tim50HA and Tim501-361-HA equally incorporate into 
the TIM23 complex. Importantly, unvaried levels of relative Tim21 dissociation from both 






























































binding domain of Tim50 is indeed dispensable for the previously established Tim50-




4.1. The Tom40 channel recognizes presequences and augments their translocation 
kinetics in route to the inner membrane. 
 The data described in this study confirms numerous publications in which Tom40 
was speculated to be a presequence interactor (Ahting et al., 2001; Gabriel et al., 2003; 
Gaikwad and Cumsky, 1994; Gessmann et al., 2011; Gordon et al., 2001; Hill et al., 1998; 
Juin et al., 1997; Kanamori et al., 1999; Künkele et al., 1998; Mahendran et al., 2012; 
Rapaport et al., 1998a; 1998b; Sherman et al., 2006; Stan et al., 2000). Specifically, the 
data presented here have effectively mapped the presequence-binding regions of Tom40 to 
two locations residing on opposite ends of the β-barrel. Moreover, an extensive literature 
analysis has confirmed previous speculations as to Tom40 regions believed to be actively 
involved in presequence association (see section 4.2. for details). Of particular interest, an 
established phosphorylation site (T220) (Schmidt et al., 2011) was seen to reside in the 
middle of one of the identified presequence interaction regions. Investigation of this site 
utilized the previously established targeted mutagenesis phospho-mimicking method 
(Gerbeth et al., 2013; Schmidt et al., 2011), entailing the creation of yeast phospho-
mimetic (T220E) and phospho-block (T220V) Tom40 mutants. Contrary to previous 
random attempts at mutating presequence-specific residues (Gabriel et al., 2003; Sherman 
et al., 2006), the novel in vivo Tom40E and Tom40V mutants presented unaltered TOM 
stability and functionality in regards to imported non-presequence related substrates. 
Moreover, the chosen method of presequence-binding site identification allowed for the 
subsequent conformation, through the very same presequence probe photo-crosslinking 
approach. In short, initial phospho-mutant analysis enabled both the conformation of the 
mapped presequence-binding domain and the involvement of posttranslational regulation 
within the binding pocket via a presently elusive kinase and phosphatase network. 
Investigation of presequence mediated TOM translocation exposed altered 
presequence mediated translocation kinetics, with mitochondria containing Tom40V 
displaying faster OM translocation kinetics. This modification resulted in an increased 
TOM binding capacity for the presequence-containing substrate, observed as a stable 
TOM-substrate intermediate under conditions in which the Δψ as depleted. Moreover, this 
particular phosphorylation-mediated fine-tuning translocation mechanism, almost certainly 
residing within a much larger regulatory network, was shown to be functionally dependent 
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upon the lone established trans-acting presequence-interacting domain, namely Tom22IMS. 
The strict dependence upon Tom22IMS observed within the Tom40 presequence-active site 
under question provides intriguing evidence of subunit cooperation within the TOM 
complex. Thus far, presequence-specific TOM subunit cooperation has been limited to the 
cytosolically exposed receptors (Shiota et al., 2011; Yamano et al., 2008), and therefore 
presents fresh insight into the thus far functionally uncharted IMS face of the TOM 
complex. 
Attempting to achieve a great depth of understanding of the newly uncovered 
Tom40 presequence import regulatory groove, saturating import analysis was performed in 
the Tom40 phospho-mutants, allowing for matrix import to be assessed as a whole. 
Captivatingly, a phosphorylation reminiscent phenotype was observed within the mutants, 
as Tom40E- and Tom40V-containing mitochondria demonstrated presequence import 
kinetics flanking that of the wild-type. Comparing both strains to the corresponding wild-
type mitochondria, Tom40V mitochondria exhibited an increased capacity for presequence 
import, as was seen in the aforementioned TOM-presequence substrate intermediate assay, 
and Tom40E mitochondria displayed attenuated kinetics. One would assume that under 
wild-type conditions, a mixed phosphorylation population of Tom40 T220 exists; therefore 
it should reflect an intermediate phenotype when compared to the two extremes, mimicked 
here by the phospho-mutants. This phospho-mutant phenotype behavior has been 
previously seen to exist within the TOM complex (Gerbeth et al., 2013). 
Finally, utilizing the saturating matrix-targeted presequence import assay within the 
Tom40 phospho-mutants in the tom22-2 background, a functional link was observed 
between the two presequence-active sites. Both Tom40E and Tom40V mitochondria 
displayed heightened sensitivity to the genetic disruption of the Tom22 IMS domain. This 
finding closely paralleled the results of the presequence-specific TOM-intermediate 
translocation assay, allowing for the gain of presequence import function seen in the 
Tom40V mutant to be attributed to a functional relationship with Tom22IMS. Additionally, 
the reduction in TOM translocation when monitored specifically is seen to lead to an 
overall reduction in matrix import when the presequence pathway is assessed as a whole. 
 
4.2. Presequence association at the TOM complex, Tom40’s role 
 The TOM complex is considered to be the master mitochondrial traffic regulator 
since all cytosolically translated substrates that are addressed beyond the outer membrane 
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must enter the mitochondrion via TOM. An overwhelming majority of these substrates are 
guided through the outer membrane by a series of presequence-binding domains embedded 
in various presequence-active TOM subunits. Tom40 has time and time again throughout 
literature been proposed to be one of these presequence-active subunits (Baker et al., 1990; 
Gabriel et al., 2003; Gaikwad and Cumsky, 1994; Gessmann et al., 2011; Gordon et al., 
2001; Hill et al., 1998; Kanamori et al., 1999; Mahendran et al., 2012; Rapaport et al., 
1997; 1998a; Sherman et al., 2006; Stan et al., 2000; Vestweber et al., 1989), yet no study 
has delineated the causal relationship between Tom40 presequence-binding and its role in 
presequence mediated import. A major contributor to this disparity is the absence of 
Tom40 structural data, however, recent publications have validated the mouse VDAC 
based homology model and have given new meaning to the interpretation of primary 
sequence interaction data (Gessmann et al., 2011; Qiu et al., 2013). However, conclusive 
data regarding the orientation of the β-barrel in the membrane is still elusive and represents 
an attractive area for further investigation. 
 In section three of this study, efforts were made to identify presequence-interacting 
regions of Tom40, which resulted in the identification of three interacting peptides. Placing 
the Tom40 residues of interest within the previously validated Tom40 homology model 
(Qiu et al., 2013), two sites were apparent, localized to opposite ends of the β-barrel. This 
finding meshed seamlessly with the existing literature as Tom40 was previously proposed 
to hold two separate cis and trans presequence interaction sites through experimentally 
demonstrated differential salt sensitivity (Kanamori et al., 1999; Mayer et al., 1995). One 
of the two mapped presequence-interacting regions was defined to a higher degree due to 
the identification of multiple photo-crosslink containing peptides within the immediate 
vicinity. Interestingly, key presequence-specific residues or regions identified by previous 
works are seen to reside within or in the surrounding area of one of the two mapped 
presequence-binding locations. 
 Gabriel and colleagues screened a library of mutant TOM40 alleles for growth 
phenotypes over a wide range of temperatures and carbon sources and identified a 
presequence-specific sorting mutant, W243R (Gabriel et al., 2003). Although this mutant 
clearly exhibited compromised TOM stability, the presequence pathway was shown to be 
selectively affected. Importantly, the observed import phenotype can now be given 
structural backing, as the mutation resides within the ß-sheet that flanks the newly 
characterized presequence-interacting region (Fig. 16, I and II). Sherman and others 
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generated several mutants corresponding to conserved stretches and identified a N. crassa 
strain demonstrating attenuated presequence mediated import while leaving the carrier 
pathway unaffected (referred to as ∆64) (Sherman et al., 2006). However, similar to the 
findings in the aforementioned study, TOM stability was significantly compromised. 
Nevertheless, the presequence selectivity can be explained via the current presequence 
mapping data, as the stretch of residues omitted are located within the ß-sheet attached to 
the identified presequence-interacting loop containing M94 (Fig. 16, III) in S. cerevisiae. 
A recent publication by Gessmann and colleagues, examining Tom40’s unique 
structural elements across a wide range of species, identified a well conserved polar groove 
within the ß-barrel’s interior (Gessmann et al., 2011). Captivatingly, this polar groove was 
not found in other OM ß-barrel proteins of high sequence identity, namely Por1 (known as 
VDAC in higher eukaryotes). This area of interest, corresponding to ß-sheets 8-11, 
perfectly coincides with the presequence-interacting region mapped and functionally 
characterized in the present study. Collectively, the presequence-interacting regions 
described here are in complete agreement with previously published data and impart new 
meaning to prior observations. 
 
4.3. Regulation of mitochondrial import via posttranslational modification at the 
TOM complex. 
Initial global-scale phosphoproteome studies in baker’s yeast (S. cerevisiae) 
identified several phosphorylation sites within mitochondrial proteins, albeit the functional 
significance of the identified regulation points remained unknown (Albuquerque et al., 
2008; Chi et al., 2007; Gnad et al., 2009; Holt et al., 2009; Li et al., 2007), yet in 2011, the 
long-elusive functional link between cytosolic kinase activity and mitochondrial import 
regulation was characterized (Schmidt et al., 2011). Schmidt and others utilized an 
exhaustive mass spectrometry approach to define the TOM phosphoproteome. In this 
trailblazing publication the authors functionally linked the actions of cytosolic kinases to 
the global regulation of mitochondrial import. Creatine kinase 2 (CK2) was shown to 
phosphorylate both Tom22 and Mim1, bringing about increased steady-state TOM 
complex levels, allowing for a higher flux of mitochondrial traffic through the OM main 
entry gate. Moreover, protein kinase A (PKA) was observed to phosphorylate Tom70 
particularly when yeast were cultured in non-fermentable media, resulting in the reduction 
of its receptor activity and the concurrent reduction in metabolite carrier import not 
required in non-respiratory conditions. Finally, for the first time, Schmidt et al. identified 
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multiple Tom40 phosphorylated residues including the residue under investigation in the 
present study, T220. Using their newly established in vitro phosphorylation system, as in 
silico kinase prediction had failed to produce any viable results, an attempt was made to 
identify the kinase responsible for the phosphorylation of Tom40 at T220. However, the 
Tom40 phosphorylation signal of the recombinant phospho-mimetic mutant (T220E) was 
unphased upon the addition of PKA, CK1, MAPK and cyclin-dependent kinase 2 (CDK2), 
which prevented the assignment of a particular kinase (Schmidt et al., 2011). 
Adding to the previously established mitochondrial import posttranslational 
regulatory mechanism at the TOM complex, Gerbeth and others further defined an intricate 
Tom22 centered TOM phosphorylation-based regulatory system (Gerbeth et al., 2013). In 
their study, glucose-induced signaling was correlated with TOM complex import 
regulation through CK1 mediated phosphorylation of the cytosolic Tom22 precursor (at a 
CK2 distinct residue), which brought about an increase in Tom22 and Tom20 import. 
Conversely, PKA’s actions on the Tom22 precursor resulted in its reduction of import. 
Collectively, the aforementioned studies showcase the existence of a phosphorylation-
based import regulatory system at the TOM complex and validate the use of the presently 
employed phospho-mimetic point mutants in the biochemical characterization of 
posttranslational regulation at the TOM complex. 
 
4.4. Tom40’s roles within the context of the posttranslationally mediated TOM 
import regulatory system. 
Having identified two presumptive presequence-interacting Tom40 surfaces, efforts 
were made to pinpoint various key residues in order to confirm and biochemically examine 
the newly defined presequence-interacting sites. Careful examination of the binding 
grooves uncovered the existence of a previously identified posttranslationally modified 
residue (T220) positioned in the middle of one of the newly identified binding surfaces 
(Schmidt et al., 2011). Through the use of previously validated, targeted phospho-active 
point mutations (Gerbeth et al., 2013; Schmidt et al., 2011), one of the presequence-
interacting regions revealed by mass spectrometry was confirmed in organello and 
functionally characterized within the context of presequence mediated import. 
Integrating previously published knowledge of presequence mediated OM 
translocation via the TOM complex with the experimentally obtained insight gained in the 
present study, the following mechanism is proposed, schematically depicted in Fig. 30. (i) 
cytosolically translated mitochondrial-targeted, presequence-containing substrates are first 
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captured by Tom20 via hydrophobic interactions (Abe et al., 2000; Brix et al., 1997); (ii) 
the presequence then forms a trimetric complex with Tom receptors Tom22 and Tom20 as 
it nears the TOM channel entrance (Shiota et al., 2011; Yamano et al., 2008); (iii) entering 
the Tom40 channel of the TOM complex, the presequence is guided to the cis-binding site 
within the β-barrel (mapped in the present study) with the assistance of Tom5 (Dietmeier 
et al., 1997; Kanamori et al., 1999; Mayer et al., 1995; Rapaport et al., 1997); (iv) the 
presequence is then pulled to the trans face of the β-barrel via its affinity to the Tom40 
trans-binding site, comprised of a Tom40 resident groove as well as the IMS domain of 
Tom22 (mapped and biochemically illustrated in the present study) (Chacinska et al., 
2003; Frazier et al., 2003; Moczko et al., 1997) or if Tom40 T220 is phosphorylated, the 
presequence is then weakly attached to the trans face of the β-barrel via the now weakened 
interaction with the Tom40 trans-binding site and concomitantly is mildly anchored to the 
IMS domain of Tom22 (experimental portrayed in the present study); (v) with the 
presequence anchored at the trans-face of the TOM complex, its is presented to the 
primary IM bound presequence translocase receptor Tim50 (Schulz et al., 2011). 
 
Figure 30. Schematic representation of presequence passage through Tom40 of the TOM 
complex. The TOM complex is illustrated on the left, depicting presequence mediated import guided 
























TOM complex is presented, highlighting the Tom40 β-barrel presequence-binding domains (shown in 
blue) which were revealed in the study, as well as the intermembrane space (IMS) domain of Tom22. 
Tom40 T220 phosphorylation by an elusive kinase functionally uncouples Tom22IMS from positive 
presequence-interaction and weakens Tom40’s grip on the translocating presequence. OM, outer 
membrane. 
 
In conclusion, Tom40 is identified in this study to serve a major role in OM 
presequence passage and is presented to function within a posttranslationally mediated 
presequence import TOM regulatory system. 
 
4.5. The dissociation of the Tim23 coordinated Tim21-Tim50 interaction is 
functionally linked to presequence translocase priming. 
 The presequence translocase is a uniquely competent inner mitochondrial 
membrane translocase as it is versed in matrix translocation, IM integration as well as the 
recently demonstrated combination thereof (Bohnert et al., 2010). Enabling the 
accomplishment of this tall order, the TIM23 complex has been characterized to be present 
in two functionally distinct isoforms, namely Tim23SORT and Tim23MOTOR (see section 
1.3.1.2. for a detailed description). The exact series of dynamic events required to convert 
a SORT TIM23 to a MOTOR TIM23 is not presently known, however, the TIM23 
complex has been demonstrated on numerous occasions to exhibit functionally relevant 
intricate dynamic subunit exchange events described in depth within section 1.3.1. of this 
work. 
 Thus far, key publications have detailed some of these dynamic events and have 
concurrently begun to decipher the individual subunit exchanges in the context of an active 
presequence translocase (Alder et al., 2008; Chacinska et al., 2005; Gevorkyan-Airapetov 
et al., 2009; Marom et al., 2011; Mokranjac et al., 2009; Popov-Celeketić et al., 2008a; 
Popov-Čeleketić et al., 2011; Schulz et al., 2011; van der Laan et al., 2005; 2007). 
However, many critical junctions are still poorly understood, specifically what are the 
events that take place when the substrate is in transit from the trans side of the OM to the 
cis side of the IM? In this study, the dynamic events instilled upon the presequence 
translocase by an inbound signal sequence were investigated; enabling IMS subunit 




4.6. A presequence priming model of matrix import by the presequence translocase  
 Placing the mechanistic knowledge gained in the current study within the confines 
of firmly established translocation-driving presequence translocase dynamic actions, the 
following mechanistic model of TIM23-mediated matrix import is advocated (schematic 
presentation portrayed in Fig. 31): (Fig. 31 - A) the default or inactive TIM23 complex is 
characterized by the core subunits of the presequence translocase Tim23, Tim17 and Mgr2, 
bound by the Tim23 coordinated Tim50-Tim21 complex, with the IMS domain of Tim50 
serving to prevent TIM23 channel opening (Meinecke et al., 2006); (B) upon presequence 
emergence from the TOM channel, it is captured by Tim50’s C-terminal presequence 
binding domain while still associated with the TOM complex (Schulz et al., 2011), 
triggering the release of the intra-TIM23 Tim50-Tim21 interaction; (C) Tim21 is released 
from the TIM23 complex upon Tim50-Tim23 interaction (Gevorkyan-Airapetov et al., 
2009), and the presequence is handed-off to the IMS domain of Tim23 with the concurrent 
recruitment of Pam17, yielding a matrix import primed translocase; (D) the TIM23 channel 
is opened through a presequence and Δψ dependent mechanism (Truscott et al., 2001) 
together with the commencement of the force-conferring cyclic actions of the ATP-
dependent PAM complex through the dynamic association of PAM subunits with the 




















Figure 31. Schematic representation of the dynamic stages of the presequence translocase 
(TIM23) during matrix import. (A) In the default TIM23 complex Tim50 and Tim21 are in close 
proximity to each other, held together via the intra membrane space (IMS) domain of Tim23. (B) 
Tim50, the primary inner membrane (IM) bound presequence receptor initially captures the 
presequence as it exits the TOM channel at its C-terminal presequence-binding domain. 
Concomitantly, Tim50 disassociates from Tim21, weakening its association to the presequence 

















































resulting in presequence hand-off. Pam17, an early acting presequence associated motor (PAM) 
component, associates with TIM23 leaving the translocase primed for matrix import. (D) The 
TIM23MOTOR complex is formed with the recruitment of additional PAM subunits, triggering the 
release of Pam17. The presequence-containing substrate is pulled into the matrix via the ATP-
dependent Ssc1 (mtHsp70) cycle, with the matrix processing peptidase (MPP) removing the 
presequence. Figure summarizes the previously published findings (Lytovchenko et al., 2013), and 
places them within the established translocation model. 
 
4.7. TIM23 dynamics 
 The presequence translocase is one of the most, if not the most, dynamic 
mitochondrial translocase as it has been described on multiple occasions throughout 
literature to be present in at least two functionally relevant isoforms: the IM integration 
competent TIM23SORT and the matrix translocation competent PAM associated 
TIM23MOTOR form (Chacinska et al., 2005; 2010; Popov-Celeketić et al., 2008a; Saddar et 
al., 2008; van der Laan et al., 2007). This inherent state of dynamic heterogeneity observed 
within the presequence translocase greatly adds to its extreme fragility upon membrane 
solubilization and is likely the single largest hurdle along the path toward high resolution 
structural data, already available for other OM and IM translocases, namely the TOM and 
TIM22 complexes (Model et al., 2008; Rehling et al., 2003). The dynamic reorganization 
is presently believed to be the consequence of the TIM23 complex “reading” and 
integrating targeting information present within the incoming substrate. This targeting data 
is present in the form of a presequence with or without a downstream stop-transfer signal. 
The stop-transfer signal is known to initiate the reorganization of an active translocase 
(Chacinska et al., 2005; Popov-Celeketić et al., 2008a), allowing for the lateral release of 
the substrate under translocation into the IM from the TIM23SORT isoform (van der Laan et 
al., 2007). The multiple isoform TIM23 model is not without critics (Popov-Celeketić et 
al., 2008a; Popov-Čeleketić et al., 2011; Tamura et al., 2009), which argue for a single 
entity model, however, its highly dynamic nature upon substrate presentation is 
uncontested within both functional TIM23 models. Importantly, publications from groups 
of both schools of thought have independently confirmed the seemly antagonistic subunit 
exchange of Tim21 and Pam17 at the active TIM23 complex (Chacinska et al., 2010; 
Popov-Celeketić et al., 2008a), which is demonstrated here to occur during the early 
translocase priming stages. However, the dynamic steps undertaken are still not 
exhaustively characterized and, in particular, the mechanism by which the presequence 
! 94!
translocase scans the bound substrate for downstream sorting information is currently 
purely speculative. 
 Previous works investigating TIM23 dynamics have employed various 
combinations of supercomplex or translocase isolation, native electrophoresis and various 
crosslinking techniques (Chacinska et al., 2005; 2010; Popov-Celeketić et al., 2008a; 
Popov-Čeleketić et al., 2011; Tamura et al., 2009), which suffer from either the lack of a 
push towards a particular isoform and/or the inability to examine the very early stages of 
translocase dynamics. Here, complex priming was achieved via presequence peptide 
incubation, in conjunction with tag-free complex isolation. This combination has allowed 
for the investigation of very early translocase dynamics in a near-native controlled fashion, 
monitoring the molecular consequences underlying isoform switching, observed here to 
involve novel dynamic intra-TIM23 complex subunit interactions. 
 Controversy amongst current models of TIM23 translocation is rooted in the degree 
of dynamic association exhibited by the PAM and Tim21 subunits. In this study, great 
strives were made to clarify these discrepancies between the two prevalent TIM23 models 
(TIM23MOTOR and TIM23SORT vs. the single entity model), especially in regards to Tim21 
dynamics. Here, when, why and how Tim21 is released from the presequence translocase 
are presented. When: Tim21 is released from TIM23 at a very early stage following 
presequence binding to Tim50. Why: Tim21 release allows for the subsequent recruitment 
of Pam17 (Popov-Celeketić et al., 2008a), which assists in ensuing PAM association 
(Schiller, 2009; van der Laan et al., 2005). How: Following presequence binding to Tim50 
at a C-terminal presequence binding domain distant recognition site, Tim21 dissociates 
from the TIM23 complex in a Tim23 dependent manner. 
Recent studies have laid the framework for the targeted investigation of 
presequence-induced TIM23 dynamics, as Tim50 is now known to be the an obligatory 
primary presequence receptor (Marom et al., 2011; Qian et al., 2011; Schulz et al., 2011). 
Advancing upon previous knowledge, the present study identified a novel presequence-
active dynamic TIM23 interaction between Tim50 and Tim21. This interaction was shown 
to be mediated by the Tim23 IMS domain and to take place specifically at the presequence 
translocase and not within a free subunit pool. Importantly, presequences were shown to 
dissipate the Tim50-Tim21 interaction, resulting in the subsequent release of Tim21 from 
the TIM23 complex and the concomitant recruitment of Pam17, leaving the presequence 
translocase primed for further PAM association and ensuing matrix translocation. 
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The initial priming events identified in the present study as well as other dynamic 
events described throughout literature allow for one to mechanistically unravel the 
presequence translocase, yet key translocation steps are still largely unknown. For 
example, what are the dynamic subunits allowing for the TIM23 complex to undergo 
isoform switching during the active translocation of a substrate and which subunits are 
responsible for the probing of a possible stop-transfer sequence the substrate under 
translocation? These questions represent only a sliver of the presently mysterious actions 
of the IM presequence translocase and indentify alluring areas of future investigation. 
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5. Summary and future perspectives 
 The present study has investigated the role played by Tom40 during the import of 
presequence-containing substrates. Using a joint photo-crosslinking mass spectrometry 
approach, validated within the mitochondrial context (Schulz et al., 2011), the presequence 
binding sites of Tom40 were mapped and placed within the recently biochemically 
validated VDAC based Tom40 homology model (Qiu et al., 2013). Pinpointing the 
locations of the long hypothesized cis and trans Tom40 presequence interaction sites 
(Kanamori et al., 1999; Mayer et al., 1995; Rapaport et al., 1998b), a previously identified 
posttranslationally modified residue (Schmidt et al., 2011), T220, was functionally 
investigated due to its unambiguous proximity to an identified presequence interaction 
groove. Through the creation of validated phospho-mimetic point mutants (Gerbeth et al., 
2013; Schmidt et al., 2011) the site of presequence interaction was confirmed and 
functionally linked to the regulation of presequence-mediate OM passage. Moreover, an 
import conferring relationship was established between the characterized Tom40 
presequence binding site and the trans-acting IMS domain of Tom22. The 
posttansloationally modified Tom40 presequence recognition site investigated in this study 
was shown to affect the flux of a matrix-targeted substrate over the entirety of the 
presequence pathway. 
 Examining the very next functionally relevant step in presequence translocation, a 
novel intra-TIM23 subunit interaction was characterized and identified to play a key role in 
the early stages of TIM23 mediated presequence import. Through the use of a short 
chemical crosslinking reagent (2 – 3 Å), Cu2+, Tim21 was identified as a Tim50 binding 
partner. The Tim50-Tim21 interaction was recapitulated in an in vitro interaction assay, 
where Tim23’s IMS domain was observed to coordinate the interaction via a Tim23-
Tim50 interaction dependent mechanism. The Tim50-Tim21 interaction was seen to occur 
at the presequence translocase and dissociate upon the addition of presequence peptides, 
triggering in the association of Pam17, leaving the translocase primed for matrix import. 
Moreover, the presequence peptide mediated priming effect on the TIM23 complex was 
revealed to occur via presequence binding to a site distant from the established primary IM 
bound receptor groove within the C-terminus of Tim50 (Schulz et al., 2011). In summary, 
the stages of presequence initiated TIM23 priming described in this study link presequence 
presentation in the IMS with the recruitment of the PAM complex, facilitating matrix 
translocation of the substrate. 
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 Looking forward to future studies, the present work raises several intriguing 
questions. As Tom40 has now been confirmed to contain two spatially distinct binding 
sites, one might assume they act in concert pulling the presequence across the outer 
membrane, a concept supported by early publications (Mayer et al., 1995; Rapaport et al., 
1998b). Utilizing the mapped Tom40 binding sites from the present study, the creation of 
cis or trans specific mutants would allow for the disentanglement of the individual binding 
grooves. Moreover, in order for these mutants to be created, the unambiguous assignment 
of the cis and trans faces of the ß-barrel is obligatory. 
 Further investigation into the novel, posttranslational substrate regulatory 
mechanism, through the identification of corresponding Tom40 T220 kinase and 
phosphatase would enable the in-depth characterization of the OM fine-tuning mechanism. 
Importantly, the presented mode of substrate kinetic regulation allows for the immediate 
and direct alteration of mitochondrial substrate flux. Previously publications investigating 
TOM posttranslational regulation uncovered a mechanism that controls the steady-state 
levels of the complex through the selective phosphorylation of TOM assembly proteins 
such as Mim1 and Tom22 (Gerbeth et al., 2013; Schmidt et al., 2011). However, this 
mechanism is not fast acting due to its dependence on the removal of existing or the 
creation of de novo TOM complex. It would follow that a fast acting, posttranslational 
presequence import, regulatory system exists as hinted on in the present study, since a 
similar Tom70 centered, carrier pathway specific regulatory network has been presented 
(Schmidt et al., 2011). Moreover, the TOM phosphoproteome study by Schmidt and 
colleagues has uncovered an explicit IMS localized phosphorylation site within Tom22IMS, 
T129. It is tempting to connect this posttranslational modification to the Tom40 T220 
centered import regulatory system addressed here, yet the exploration of IMS localized 
kinases and phosphatases is a largely unexplored field with only a small number of soluble 
perspective members recently identified (Vögtle et al., 2012). These two areas of 
presequence interaction are presented here to be functionally linked and represent a prime 
target for future investigations examining the functional consequences to presequence 
import brought about by Tom40 T220 and Tom22 T129 phosphorylation. 
 The import mediating substrate interactions of the trans face of the TOM complex 
is poorly understood to this day. This is highlighted when one compares the rich wealth of 
publications investigating the cytosolic facing subunits of the TOM complex with the 
nearly inexistent number examining the functionality of the IMS exposed subunits. In 
regards to the present findings, two underlying questions arise: (i) what is the nature of the 
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observed functional cooperation of Tom40 and Tom22IMS at the trans surface of the TOM 
complex, specifically does sandwiching of the presequence take place similarly to the 
speculated joint presequence binding by Tom20 and Tom22 at the cis face?; (ii) what is the 
role of IM anchored receptors during late stage TOM translocation, in particular the 
delineation of the previously observed stabilization function of Tim50 in TOM 
intermediates (Chacinska et al., 2005)? 
 At the IM, the TIM23 complex was shown to undergo a series of intra-translocase 
dynamic interactions, resulting in the matrix import primed presequence translocase. The 
knowledge gained in the present work would best be supplemented with the investigation 
of two prominent issues. The first of which is recognized by the restrictions to the priming 
mechanism presented here, as it is confined to the import of matrix-targeted substrates. 
This downfall highlights the present void of knowledge regarding the mechanism by which 
TIM23 scans the substrate under translocation for downstream sorting information and 
subsequently initiates isoform switching. The second issue is observed when one carefully 
scrutinizes the late stages of the model presented. Explicitly, how are the dynamics of the 
PAM subunits linked to the force conveying actions of the motor complex? This issue is 
presently under intense investigation within the mitochondrial import field (Chacinska et 
al., 2009; van der Laan et al., 2010), as a functional model of the PAM complex is lacking. 
 The notion of membrane spanning translocase cooperation is brought front and 
center when the two topics investigated in the present study are brought together, the 
functional characterization of late stage presequence-containing substrate TOM 
translocation and the indiscriminately associated presequence translocase priming steps. 
This concept has been toyed with since the initial observation of translocation 
supercomplexes (Schleyer and Neupert, 1985), yet the functional significance of 
supercomplex formation is still unknown. Expanding upon our understanding of 
coordinated inner and outer membrane bound receptor interactions will greatly contribute 
towards a comprehensive understanding of mitochondrial import and lead to the step-by-
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